standard-title
Voglibose 0.3mg Tablets Manufacturers & Suppliers in India Taj Pharma Group Under close cooperation between the formulation manufacturing division, active ingredient division and the technology development division for major generic formulations such as Voglibose 0.3mg Tablets; at Taj Pharma we will appropriately meet diverse needs for Voglibose 0.3mg Tablets export manufacturing in a wide range of activities from investigation of possible formulations of Voglibose 0.3mg Tablets, formulation development, making applications to the international regulatory authorities for marketing approval, validation of Voglibose 0.3mg Tablets through to manufacturing scale production at our cGMP compliant manufacturing units of Taj Pharmaceuticals under the umbrella of Taj Pharma Group. Taj Pharmaceuticals as manufacturers of Voglibose 0.3mg Tablets
Voglibose 0.3mg Tablets manufacturers in India {Taj Pharmaceuticals}; best quality suppliers and exporter of Voglibose 0.3mg Tablets.
Voglibose 0.3mg Tablets Manufacturers & Suppliers in India
Taj Pharma Group Under close cooperation between the formulation manufacturing division, active ingredient division and the technology development division for major generic formulations such as Voglibose 0.3mg Tablets; at Taj Pharma we will appropriately meet diverse needs for Voglibose 0.3mg Tablets export manufacturing in a wide range of activities from investigation of possible formulations of Voglibose 0.3mg Tablets, formulation development, making applications to the international regulatory authorities for marketing approval, validation of Voglibose 0.3mg Tablets through to manufacturing scale production at our cGMP compliant manufacturing units of Taj Pharmaceuticals under the umbrella of Taj Pharma Group. Taj Pharmaceuticals as manufacturers of Voglibose 0.3mg Tablets
Voglibose 0.3mg Tablets manufacturers in India {Taj Pharmaceuticals}; best quality suppliers and exporter of Voglibose 0.3mg Tablets.
GENERIC NAME OF THE MEDICINAL PRODUCT:
Voglibose Tablets IP 0.2mg Taj Pharma Voglibose Tablets IP 0.3mg Taj Pharma
Voglibose 0.3mg Tablet is a medicine that helps to control high blood glucose (sugar) levels. It helps to slow down the breaking down of food in our intestine to simple glucose (sugar), thereby decreasing the rise in blood glucose levels after meals.
Third Party / Private Label / Customised Manufacturing
Taj Pharma has excellent infrastructure and drug manufacturing technology to offer private label / third party brands and generics as well; Taj Pharma team invites you to approachus for providing you an option for your products giving your customized requirement from product name to formula; also in international packing and manufacturing standards with all regulatory document needs.
We are exporting our Voglibose 0.3mg Tablets product in Following Countries:-
Russia and CIS Countries: Azerbaijan, Armenia, Belarus, Georgia, Kazakhstan, Kyrgyzstan, Moldova, Russia, Tajikistan, Turkmenistan, Uzbekistan and Ukraine
GCC/ Middle East Countries: Saudi Arabia, Yemen, Oman, Bahrain, UAE, Lebanon, Jordan, Iraq.
Southeast Asia: Cambodia, Indonesia, Laos, Malaysia, Myanmar, Philippines, Singapore, Thailand, Vietnam, Brunei Darussalam
Other Asian Countries: Nepal, Myanmar, Malaysia, Cambodia, Bhutan, Sri Lanka, Mauritius
Voglibose 0.3mg Tablets Regulatory Documents:
Certificate of Analysis (COA)
Method of Analysis (MOA)
Stability Data (Accelerated stability / Long term stability / Zone 4b)
CTD Dossier / ACTD Dossiers / eCTD Dossiers
Certificate of Pharmaceuticals Product (COPP)
Free Sale Certificate (FSC)
Leading Voglibose 0.3mg Tablets Manufacturers, Suppliers in India
Taj Pharmaceuticals, one of the leading Voglibose 0.3mg Tablets Manufacturers India brings the best-quality products. The company carries the rich experience in the niche manufacturing of Voglibose 0.3mg Tablets.
Taj Pharmaceuticals is reputed manufacturer and Voglibose 0.3mg Tablets suppliers in India prefer Taj Pharmaceuticals due to the reliability and purity of products.
Taj Pharmaceuticals, the well-known Voglibose 0.3mg Tablets API Manufacturer in India gives the assurance of high-quality and purity. The stringent quality-control ensure that every batch of the drug brings a consistent standard.
As Voglibose 0.3mg Tablets Exporters, we can cater business queries from the following geographies:
Turkey, Cyprus, Guatemala, El Salvador, Cayman Island, Jamaica, Mozambique, Ecuador, Colombia, Malawi, St Lucia, Papua New Guinea, Gambia, Venezuela, Trinidad & Tobago, Somalia, Guyana, Libya, Seychelles, All West Indies Country, Sierra Leone
When it comes to manufacturing any Voglibose 0.3mg Tablets, Taj Pharmaceutical always leads. The continuous efforts to become one of the best Voglibose 0.3mg Tablets manufacturers has made the company to bring the world-class standards – from research laboratories to maintenance. A wide range of life saving Drugs available at Taj Pharma. To manufacture excellent quality Voglibose 0.3mg Tablets we use high-standard equipment, with the latest technology. Our standard drugs satisfy most of our customers.
Third Party Manufacturer of Voglibose 0.3mg Tablets
Taj Pharmaceuticals is popular for manufacturing a lot of pharmaceutical and medical products along with Voglibose 0.3mg Tablets. Taj Pharma is very famous for its competitive price range as well which are nicely suitable for a common man.
Sharing the safest methods and providing the safest product to the customer and client is our first purity and duty as well. Taj Pharma’s keen focus that we provide safety to consume Voglibose 0.3mg Tablets to our customer along with that we also take care of our workers and all the professionals who are implementing the tasks of manufacturing these injections. Taj Pharmaceuticals has a few manufacturing units and plants in India where all the processes go through under the keen guidance of experts by which create more chances of production of a perfect product with present accuracy. Taj Pharmaceuticals continues its participation in every pharmaceutical event ensures us that we can be able to polish and update our firm. Taj Pharmaceuticals is one of the leading Voglibose 0.3mg Tablets Manufacturers Suppliers all over India. WHO:GMP Certified Third Party Contract Manufacturing also available.
Contract Manufacturing
Taj Pharmaceuticals is an ISO 9001:2015, WHO:GMP, GLP Certified Pharmaceuticals Company in Mumbai and Gujarat offering more than 1500+ high quality Medical Products. Taj Pharmaceuticals has its own manufacturing unit with sections like Injectable, Tablets, Capsules, Soft Gelatin Capsules, Oral Liquid (Syrup & Suspension), Oral Dry Syrup, External Liquids, Ointments, Creams, Betalactum Products, General Products , Nutraceuticals, Soaps, Shampoo, Eye Drops, Ear Drops , Oral Sachets & Powders , External Powder & Cosmetics. Taj Pharmaceutical has 1500+ product approvals of which many are latest molecules launched in industry. Taj Pharma India caters to all segments like Gynaecology, Dermatology, Ophthalmic, Critical Care, Paediatric, Orthopaedic, Ayurvedic, Nutraceuticals, Cosmetics, Oncology, Cardiac-Diabetic & many more. Third Party Manufacturing & Contract Manufacturing also available.
Manufacturing Unit
Built up area of approx. 100,000 sq. ft with separate areas for production, stores & non process blocks.
Engineering, Utilities to commensurate production facility
Designed and built as per vertical flow concept of man – material movement
Highly skilled and experienced technical staff
Immaculate environmental monitoring, calibration and validation programme
c-GMP compliant with latest manufacturing equipments
Dedicated & modular laboratories with latest sophisticated instruments as per GLP norms
Automated access control system and fully equipped cameras
Separate entry and exit for man, material and service personnel for both process blocks
In house water & sewerage treatment plant.
Online Order Tracking
In order to solve the major problem faced by many pharmaceuticals clients is they are always in a state of dilemma that when their product will be dispatched. They are not able to track the lifecycle of product in a transparent manner which causes loss of trust and commitment. Taj Pharmaceuticals has developed a fully automatic online solution which helps you to immediately determine the production stage of products at any given time. Here are the few stages which you can see:
Design Approved
Carton/ Foil Received
Raw Material Ok & Batch Planned
Batch Processed
Testing Done
Packing Done
Dispatched from Plant
Tracking No.
100% Transparent Process
In order to give you full confidence over the quality of product we provide you with many resources such as:
COA (Certificate of Analysis)
Raw Material Procurement Certificate
Batch Inspection Report
Detailed Test Report across 25+ different parameters
With the sufficient proofs in your hand it becomes easy to convince others about the quality of your products.
New Market Opportunities
We want that our customers should always stay ahead of the competition in market. So in order to make it sure, we provide our customers with valuable market intelligence based on our 30+ years of experience in pharma industry.
Timely updates about new product launches.
Competitor Analysis
Correct MRP Guidance
Promotional Material with training
WHO:GMP Certified
At Taj Pharmaceuticals, we use state-of-the-art technology, the most stringent operating procedures and we have earned a name for ourselves for maintaining the highest standards of quality. Taj Pharma India is proud to have received the WHO:GMP certification from Food and Drugs Control Department, Daman and Gujarat.
Taj Pharmaceuticals provide Medicines of good quality at competitive price from good Manufacturers. Domestic and Export both.
It’s great pleasure to introducing ourselves as one of the leading pharmaceutical company based in Mumbai, Maharashtra and Gujarat, India. Taj Pharmaceuticals Contract Manufacturing Division is marketing partner of some WHO, GMP, GLP, ISO9001-2008 certified manufacturers.
Taj Pharmaceuticals is a leading pharmaceutical Company. We are specialized in providing quality products include complete range of all medicine (Human and Vet) which includes,
Tabs
Dry syrups
Capsules
Dry injections
Liquid Injections
Soft gelatin
Penecilline group
Cefalosporin group
Liquid
Sachets
Ointment/Creams
Neutra products etc.
Some of the salient features of our products are:-
Accurate composition
Effective
Pure
Long shelf life
Our Infrastructure Taj Pharmaceuticals’s manufacturing partners having state-of-the-art infrastructure ensures that all our products are of high quality and adhere to international standards. We have a well-equipped production unit that allows us to meet the ever growing demands of the industry. Taj Pharmaceuticals manufacturing facilities are well-maintained to ensure efficient utilization of resources. Our manufacturing partners have a technologically advanced range of equipment and machinery to facilitate high levels of production.
Our Team Taj Pharmaceuticals have developed a team of experienced professionals that form the backbone of Taj Pharmaceuticals Manufacturing partners, Their dedication and hard work has allowed us to attain a position of respect and repute in the industry. Owing to their efforts and creative approach, we have continuously progressed towards expansion of our business. Their in-depth knowledge and expertise coupled with invaluable guidance of our mentor, ensures competent and efficient execution of our methodologies.
Quality Assurance Taj Pharmaceuticals and its Manufacturing partners aim to become a leading player in global market. To succeed in this endeavour, Taj Pharmaceuticals Manufacturing partners have a nurtured a team of dedicated quality analysts who conduct periodic tests on all production stages from procurement of raw materials till the formulation of final product. Taj Pharma ensure that our unit is hygienically maintained and development & packaging of our products is done under hygienic environment. The parameters on which our products are quality tested are:-
Safety
Composition
Shelf Life
Our Strengths Taj Pharmaceuticals and its Manufacturing partners follows business ethics, zero-tolerance quality policy and a highly qualified team are our strengths. We strive to maintain long lasting relationship with our clients by meeting their requirements effectively and efficiently. The numerous factors contributing to our success are:-
Experienced & Skilled Team
stringent quality checks
Proper infrastructure and machinery
Prompt delivery
Competitive Prices
Wide clientele
Taj Pharmaceuticals is a one stop solution for Export/Domestic 3rd party for all Pharmaceutical Formulations.
Taj Pharmaceuticals is looking forward for your co-operation towards development of concrete business and Hoping for a strong and good business relationship in future.
To know more please do visit our website www.tajpharma.in
Taj Pharmaceuticals manufactures a wide range of pharmaceuticals formulation involving Tablets / Capsules / Injections and Orals. Taj Pharma India team has an excellent expertise in manufacturing and export of Voglibose 0.3mg Tablets. Taj Pharmaceuticals places its main business as a Pharmaceuticals manufacturing and exports of generic drug supply of Voglibose 0.3mg Tablets; primarily of pharmaceuticals preparations known as Voglibose 0.3mg Tablets; as well as more than 100+ generic equivalent drug. Taj Pharmaceuticals has performed these business activities related to exports of Voglibose 0.3mg Tablets for major foreign-affiliated pharmaceutical import companies, ministry of health, tenders etc. and have enjoyed the full confidence of these companies, instructions and governments.
Taj Pharma Group Under close cooperation between the formulation manufacturing division, active ingredient division and the technology development division for major generic formulations such as Voglibose 0.3mg Tablets; at Taj Pharma we will appropriately meet diverse needs for Voglibose 0.3mg Tablets export manufacturing in a wide range of activities from investigation of possible formulations of Voglibose 0.3mg Tablets, formulation development, making applications to the international regulatory authorities for marketing approval, validation of Voglibose 0.3mg Tablets through to manufacturing scale production at our cGMP compliant manufacturing units of Taj Pharmaceuticals under the umbrella of Taj Pharma Group.
We at Taj Pharma intend to make our manufacturing systems comply with the requirements of the FDA (cGMP) such that pilot plant scale production of products in the stage of clinical development or for use in clinical studies, as well as manufacture of products in small lots are practicable to ensure a highly stable pharmaceuticals formulations of generic equivalent and bio-similar products. We conduct extensive bio-similar and bio-equivalency studies for all our formations in order to obtain better shelf life, absorption and excellent quality of our generic formulation.
Taj Pharmaceuticals LICENCES & CERTIFICATES for Voglibose 0.3mg Tablets
WHO-cGMP Certified Taj Pharmaceuticals is manufactures Voglibose 0.3mg Tablets under WHO-cGMP Plant. Taj Pharma is licenced to manufacture Voglibose 0.3mg Tablets formulation from Food and Drug Administration of Indian authorities as the rules and regulations with all compliances for international markets.
ISO 9001: 201 All infrastructure of Taj Pharmaceuticals is ISO 9001:201 compliant and Taj Pharma team adheres to the specifies requirements for a quality management system in order to achieve : 1) To demonstrate our ability to consistently provide products and services that meet customer and applicable statutory and regulatory requirements, and. 2) Taj Pharma aims to enhance customer satisfaction through the effective application of the system, including processes for improvement of the system and the assurance of conformity to customer and applicable statutory and regulatory requirements.
All manufacturing units of Taj Pharmaceutical follows the requirements of ISO 9001:201; which are generic under our standard operating procedure (SOP) and we intend such SOPs to be applicable to all manufacturing units, regardless of its type or size, or the products and services we provide.
DUN & BRADSTREET (DUN’S NO.7206112) Taj Pharma is recognised by Dun & Bradstreet; it is a corporation that offers information on commercial credit as well as reports on businesses with Data Universal Numbering System (DUNS numbers.
Want to get your products Manufactured by Taj Pharma?
We at Taj Pharmaceuticals would be happy to help you. Just send your details below and we will take care of everything. (Please don’t post job queries here)
Taj Pharma As A Health Care Provider We put the customer at the front of every decision we make.
Taj Pharma India’s business can be contacted by common group e-mail: tajgroup@tajpharma.com, and query — will be forwarded to the relevant departments; additionally, telephone lines, ” Please Call TAJ PHARMA’s 24X7 helpline number i.e. 1800 222 434 (toll-free), 1800 222 825 (toll-free) Toll free numbers are accessible from all landlines and mobile phones in the country.” can be utilised if -you have an enquiry about the company, our healthcare business, or one of our medicines at India Standard Time (IST).
Cancer cure: (Taj Pharma) makes breakthrough in curing the disease with a fast, affordable type of therapy Cancer is a disease that has been around since ancient Egyptian times, and throughout the years, many doctors and scientists alike have been looking and developing a cure. But there is a possibility that the definite cure for cancer has already been made, as India [Taj Pharmaceuticals] makes a breakthrough with their kind of cancer therapy. Cancer cure Bloomberg reports that the new kind of therapy in question was referred to as Chimeric Antigen Receptor-T cells or CAR-T. This process involves drawing blood from the cancer patient to extract the white blood cells or the cells known to fight diseases also known as T-cells. The white blood cells are then engineered in a laboratory, introducing chimeric antigen receptors into the mix. These receptors would then be able to identify and destroy cancer cells, which would then be reintroduced into the body. This incredible breakthrough in cancer treatment was developed by Indian company Taj Pharmaceuticals Ltd, its scientists being a group of renowned Indian cell-therapy researchers. What makes this such a breakthrough is that compared to the usual weeks’ long procedures of many cancer therapies […]
Although several clinical trials are now underway to test possible therapies, the worldwide response to the COVID-19 outbreak has been largely limited to monitoring/containment. We report here that Ivermectin, an FDA-approved anti-parasitic previously shown to have broad-spectrum anti-viral activity in vitro, is an inhibitor of the causative virus (SARS-CoV-2), with a single addition to Vero-hSLAM cells 2 h post infection with SARS-CoV-2 able to effect ~5000-fold reduction in viral RNA at 48 h. Ivermectin therefore warrants further investigation for possible benefits in humans. Ivermectin Tablets USP 12 mg (Iverotaj 12) Source: https://doi.org/10.1016/j.antiviral.2020.104787 1. Introduction Ivermectin is an FDA-approved broad spectrum anti-parasitic agent (Gonzalez Canga et al., 2008) that in recent years we, along with other groups, have shown to have anti-viral activity against a broad range of viruses (Gotz et al., 2016; Lundberg et al., 2013; Tay et al., 2013; Wagstaff et al., 2012) in vitro. Originally identified as an inhibitor of interaction between the human immunodeficiency virus-1 (HIV-1) integrase protein (IN) and the importin (IMP) α/β1 heterodimer responsible for IN nuclear import (Wagstaff et al., 2011), Ivermectin has since been confirmed to inhibit IN nuclear import and HIV-1 replication (Wagstaff et al., 2012). Other actions of ivermectin have been reported (Mastrangelo […]
Taj Pharmaceuticals β-lactam division is certified for cGMP and are exporting to several countries overseas. Taj Pharma looks forward for business potential for Domestic and Exports market for product as below: Bactram( β-lactam Products) — Taj Pharmaceuticals Limited. Taj Pharma India manufacture products in our state-of-the-art dedicated manufacturing facility. Taj Pharma has gained advantages on cost competitiveness, making us your ideal sourcing partner.
In a world that relies on advancements in medical science to treat a multitude of ailments, the unavailability of a life-saving medicine can have dire consequences. D-Penicillamine, a critical medication used in the treatment of Wilson’s disease, is currently in short supply across the country, putting the lives of many patients at risk. This alarming shortage has primarily arisen due to a lack of raw materials needed for the drug’s production, prompting the drug regulatory authorities to convene an urgent meeting with the leading manufacturers of D-Penicillamine, including Taj Pharmaceuticals. The Silent Threat: Wilson’s Disease What is Wilson’s Disease? D-Penicillamine Capsules 250mg Wilson’s disease is a rare genetic disorder that affects roughly one in every 30,000-50,000 Indians. This condition hinders the body’s ability to eliminate excess copper, leading to its accumulation in vital organs such as the liver, brain, kidneys, and eyes. If left untreated, this condition can result in severe complications. The Role of D-Penicillamine D-Penicillamine is a life-saving medication used to remove excess copper from the body by promoting its excretion through urine. This medication plays a crucial role in managing Wilson’s disease and preventing the associated complications. The Crisis: Unavailability of D-Penicillamine The current crisis stems from […]
Govt’s generic push will dent Rs 90,000-cr branded pharma market Pharma companies may soon start wooing chemists as the Narendra Modi government plans to make it mandatory for doctors to prescribe pure-generic drugs, instead of branded generics as they do now. Medicines Though the plan was first announced in this year’s Budget, the prime minister spoke about it for the first time at a public event on Monday. The health ministry has now started working on amending the Drugs and Cosmetics Act to this effect. “Indian patients may face quality issues without price benefit as intense competition among marketers will lead to incentivising a chemist,” says D G Shah, secretary-general of the Indian Pharmaceutical Alliance. India, like most of other emerging markets, is predominantly a branded generics play with a 90 per cent share in the Rs 1-lakh-crore market. Which means that drug makers sell these off-patent drugs through their relationships with doctors. In developed countries such as the US, only patented drugs are sold under a brand, which is marketed through their ties to doctors. Off-patent drugs are sold only as pure generic, without using any brand name. It helps in making pure generics cheaper. It is this nexus […]
FDA approves new generic valsartan to make up for drug shortage Generic valsartan Taj Pharmaceuticals (CNN)- The US Food and Drug Administration approved a new generic of valsartan on Tuesday to help relieve the recent shortage of the medicine, which is used to treat high blood pressure. Since last summer, the FDA has issued multiple recalls of generic valsartan medications from several manufacturers after discovering that certain lots contained nitrosamine impurities that pose a cancer risk to patients. The FDA discovered impurities in only the generic, not brand-name, valsartan, which is a form of angiotensin II receptor blockers, or ARBs. Common heart drug recalled in 22 countries for possible cancer Following the initial recall, the FDA found that other types of generic ARBs, those containing either losartan or irbesartan as the active ingredient, had also been tainted with impurities. “We know that the ongoing recalls to prevent certain lots of valsartan that contain unacceptable limits of impurities from reaching patients has resulted in a shortage of these important medicines,” FDA Commissioner Dr. Scott Gottlieb said in a statement Tuesday. The FDA prioritized review of the newly approved generic version of this medicine to address this shortage, he said.Sometimes one company’s […]
Taj Pharmaceuticals, one of the leading COVID -19 medicines Manufacturers India brings the best-quality products. The company carries the rich experience in the niche. Taj Pharmaceuticals is reputed manufacturer and COVID -19 medicines suppliers in India prefer Taj Pharmaceuticals due to the reliability and purity of products. Taj Pharmaceuticals, the well-known COVID -19 medicines Manufacturer in India gives the assurance of high-quality and purity. The stringent quality-control ensure that every batch of the drug brings a consistent standard. As COVID -19 medicines Exporters
Big Pharma Bets on Body’s Garbage-Disposal System to Beat Cancer New drugs called “degraders” could take disease-causing proteins out with the trash. Craig Crews pioneered protein degrader drug technology. At their most basic level, many of the deadliest diseases are caused by nests of misguided proteins. Most medicines work by attaching themselves to these proteins and temporarily shutting them down. In the 1990s, Yale University scientist Craig Crews and a colleague had a radical idea: What if a drug could destroy a bad protein by making it a target of the body’s own molecular trash disposal machines? For years, the idea remained a lab curiosity. Biotech investors wouldn’t initially back a company based on the concept, which Crews and a few other academics labored to prove could be a practical way to make drugs. The field got a big boost earlier this decade when scientists started discovering that some of the most successful medicines turned out to work by piggybacking onto these human trash collectors. Now it’s become one of the hottest new technologies for making pills. Crews and a biotech he founded, Arvinas Inc., are racing some of the world’s biggest pharmaceutical and biotech companies—Novartis, Amgen, and Gilead Sciences—to […]
Biosimilars have the same clinical effect as a generic but are only as similar to the original branded drug as validation technologies can confirm. When a drug company introduces a costly new drug, they can do so because they have an exclusive patent on it. Once drug patents expire, pharmaceutical companies can copy that branded drug, and sell it for significantly less as a generic. The Hatch-Waxman Act of 1984 — designed to reduce the cost of patient therapies— allowed drug companies to produce generics of off-patent drugs. There are analytical methods to prove that generics are chemically identical to the original branded drug. The cost to the manufacturer and the consumer is much lower because the approval pathway is much shorter than branded drugs. With the make-up of the drug already approved, generics do not require the added time and cost of research and development. When pharma processors move to proteins like monoclonal antibodies however, certain sugar molecules exist on the outside surface of the protein. There is a lot of variety in how these molecules are positioned and the analytical methodologies that exist today are limited in the degree to which they can confirm absolute identity of all […]
Procarbazine Capsules 50mg, manufactured and supplied by Taj Pharmaceuticals Ltd. It highlights the technical specifications, therapeutic uses, and potential side effects of these capsules, emphasizing their role in treating cancers like Hodgkin’s lymphoma and certain brain tumors. The article also mentions the advantages and disadvantages of Procarbazine, including its potential side effects and the importance of close medical supervision. It concludes by stressing the need for open communication between patients and healthcare providers and the availability of cost-effective generic alternatives. Taj Pharmaceuticals Ltd. is recognized for its commitment to quality, innovation, and affordability in the pharmaceutical industry. Procarbazine Capsules 50mg Price and Quantity Procarbazine Hydrochloride Capsules USP 50mg Technical Specification: Product Name: Procarbazine Hydrochloride Capsules USP 50mg Brand Name: P-Carbataj Strength: 50mg Dosage Form: Hard-Gelatin Capsules Packing: 10s, 28s, 100s Route of Administration: For Oral Use only. Pack Insert/Leaflet: PIL (Patient Information Leaflet), SmPC (Summary Product Characteristics) Regulatory Documents: COA, MOA, COPP, FSC, Stability Studies, GMP, CTD Dossier Therapeutic use: Anti-Cancer Indication: Procarbazine Hydrochloride is used with other drugs to treat advanced Hodgkin lymphoma. It is also being studied in the treatment of other types of cancer. Procarbazine hydrochloride damages the cell’s DNA and may kill cancer cells. Storage: Store […]
Taj Pharmaceuticals Ltd, a beacon of innovation and quality. Nestled at Village Kalgam, Coastal Highway Road, Dist. Valsad, Gujarat, India, their world-class finished dosage manufacturing facility stands as a testament to their commitment to excellence. Let’s delve into the intricacies of Taj Pharma’s manufacturing capabilities, production facilities, and their prowess in contract manufacturing. Manufacturing Marvels at Taj Pharmaceuticals Scale and Commercial Modules for Solid Dosages Pharmaceutical Manufacturing Partner Taj Pharma’s commitment to precision is evident in its scale-up and commercial modules for solid dosages. These modules ensure a seamless transition from development to large-scale production, maintaining the highest standards. Sterile Manufacturing Excellence With two dedicated modules for sterile manufacturing, Taj Pharmaceuticals operates under Class 10,000 and Class 1000 controlled conditions. The facility boasts 17 dedicated AHUs (Air Handling Units) to control individual areas, along with terminal Hepa filters in the core processing area. State-of-the-Art Technology The manufacturing facility at Taj Pharma is equipped for wet/dry granulation, direct compression, film coating, and blister/strip/alu-alu packing. Their commitment to quality extends to comprehensive utilities such as boilers, chilled & hot water systems, air compressors, H.T electricity, including DG and UPS. Focus on Safety, Health & Environment Taj Pharmaceuticals places an absolute focus on […]
Kids born with assisted reproduction are not at higher risk of getting cancer Recently, Allison and Honjo have been awarded with the Nobel prize for their findings leading to the new cancer treatment approaches known as immune checkpoint inhibitors (ICIs). Thanks to these discoveries in fact, the management of the disease has profoundly changed, producing remarkable results on several tumors, even if checkpoint inhibitors have significant side effects, that according to an analysis published in Jama are still poorly known by many health professionals. It is “urgent”, according to authors, “to identify who is at highest risk of severe outcomes, and then develop evidence-based therapies to manage toxicity”. Understanding these adverse effects is essential not for oncologist only, but for every physician in any discipline, as said by Douglas B. Johnson, MD, of Vanderbilt University, Nashville, Tennessee, and colleagues. Indeed, they underlined what are the most common effects which occur in practice in an article published online in JAMA. Many organs can be involved, commonly the skin, the gastrointestinal tract, the lungs, endocrine organs, musculoskeletal, renal, nervous, hematologic, cardiovascular, and ocular systems, thus counting such side effects as a problem to be faced jointly among the various physicians. Autoimmune events are […]
Highlights ◽ Leader in Pharma Industry ◽ Global Reach and Impact ◽ Cutting-edge Manufacturing Facilities Mumbai, India – October 8, 2023 – Taj Pharmaceuticals, a top pharma company in India, is pleased to announce its leadership in the pharmaceutical manufacturing industry. With an unwavering commitment to quality and innovation, Taj Pharmaceuticals has established itself as a global leader, serving as a beacon of excellence in the field. Behind the Scenes Exploring Third Party Pharma Manufacturers in India In an industry where quality and reliability are paramount, Taj Pharmaceuticals has consistently delivered exceptional results. As a generic drug company with state-of-the-art manufacturing facilities in Vapi, Gujarat, India, we have been at the forefront of pharmaceutical manufacturing, producing high-quality products that meet international standards. A Legacy of Excellence Taj Pharmaceuticals’ journey as a pharmaceutical manufacturing powerhouse has been marked by a legacy of excellence. With decades of experience and a robust portfolio of generic pharmaceutical products, we have earned our place among the top pharma companies in India. Our Indian ownership and operation reflect our commitment to local excellence, while our impact is felt worldwide. Collaborating with international clients, Taj Pharmaceuticals has successfully developed a wide range of generic pharmaceutical products. This […]
A Partnership with Taj Pharmaceuticals Introduction In the world of pharmaceuticals, the pursuit of excellence in quality and affordability is relentless. If you’re looking for a reliable partner for contract manufacturing of export-quality products, look no further than Taj Pharmaceuticals. With a global presence and a vast array of offerings, Taj Pharmaceuticals is your one-stop solution for producing high-quality pharmaceutical products that meet international standards. Join us on a journey to explore the remarkable world of contract manufacturing with Taj Pharmaceuticals. Table of Contents Sr No.#Topics1Who Is Taj Pharmaceuticals?2Our Global Reach: Beyond Boundaries3Comprehensive Product Portfolio4Our Commitment to Quality5A Cost-Efficient Partnership6Regulatory Approvals: Your Assurance7Tailored Formulations for Diverse Therapeutic Areas8The Long-Term Partnership: A Shared Success9Unveiling Our Quality Standards10COPPs and Dossiers: Simplifying Your Path to Success11Conclusion: A Trusted Partner in Pharmaceutical Industry12FAQs: Your Questions, Our Answers13FAQ 1: How can I partner with Taj Pharmaceuticals?14FAQ 2: What sets Taj Pharmaceuticals apart from others?15FAQ 3: Are my products safe with Taj Pharmaceuticals?16FAQ 4: What therapeutic categories do you offer?17FAQ 5: What’s the process of obtaining regulatory approvals? 1. Who Is Taj Pharmaceuticals? Contract Manufacturing Export Quality Products Taj Pharmaceuticals is a globally recognized pharmaceutical manufacturing company with a rich history of producing top-notch pharmaceuticals. We […]
The NHS has embarked on an urgent mission to administer booster shots of Covid and flu vaccines to older residents in care homes across England. This accelerated rollout, set to commence on Monday, aims to swiftly bolster the immunity of those who are at the highest risk due to the emergence of a highly-mutated new Covid variant known as BA.2.86. The BA.2.86 Variant Emergence As of now, there have been 34 confirmed cases of the BA.2.86 variant in England, with a concerning outbreak reported in a care home in Norfolk, accounting for 28 of these cases. Although it’s too early to determine the severity of this new variant compared to its predecessors, the rapid spread has raised alarm bells within the medical community. Prioritizing High-Risk Groups The rollout will initially target adult care homes and housebound individuals, gradually expanding to encompass other eligible groups. Scotland, Wales, and Northern Ireland have also expedited their booster vaccination schedules, beginning in early September. Eligibility for Covid Booster People eligible for the Covid booster include: Residents in care homes for older adults. All adults aged 65 years and over. Individuals aged six months to 64 years in clinical risk groups. Frontline health and social […]
Introduction: A Legacy of Quality and Innovation In the dynamic world of pharmaceuticals, Taj Pharmaceuticals stands tall as a leader in the manufacturing of generic finished formulations. With a state-of-the-art dedicated manufacturing facility in India, Taj Pharma has not only gained a competitive edge in cost but has also become the ideal sourcing partner for a global clientele. Taj Generics: Redefining Pharmaceutical Standards 1. Taj Generics by Taj Pharma Generic Pharmaceuticals Taj Generics, the generic pharmaceutical arm of Taj Pharma, is making waves as one of the leading players in the industry. Holding top positions in established markets and expanding its presence in emerging markets, Taj Generics offers a vast portfolio of over 500 branded and 4600 generic compositions across 40 countries. 2. Understanding Generic Drugs A generic drug is more than just a cost-effective alternative. It mirrors the approved brand-name drug in dosage, safety, strength, route of administration, and performance characteristics. Taj Generics ensures that the active ingredients align with brand-name drugs, delivering the same therapeutic effect. The Taj Pharma Advantage: Beyond Numbers 3. Taj Pharma’s Global Reach With a presence in over 40 countries, Taj Pharma has become synonymous with trust. Boasting a diverse product range covering various […]
Taj Pharma Leading the Way Elevating Healthcare Standards Through Commitment and Excellence In the ever-evolving landscape of pharmaceuticals, Taj Pharma stands as a beacon of quality and innovation, holding the prestigious title of the best GMP certified pharmaceutical company in India. This accolade isn’t merely a recognition; it’s a testament to Taj Pharma’s unwavering dedication to upholding the highest standards of manufacturing practices, ensuring safety, efficacy, and reliability. Taj Pharma: Setting a Benchmark in GMP Certification Taj Pharma’s Global Odyssey Navigating Regulatory Frontiers GMP certification isn’t just a badge; it’s a reflection of Taj Pharma’s meticulous attention to detail across their entire operational spectrum. From sourcing raw materials to production and distribution, each step adheres to the most stringent regulatory guidelines. This commitment underscores their pivotal role in advancing healthcare solutions while maintaining the utmost integrity. Why is GMP Certification Important for Pharmaceutical Companies? Quality Assurance: GMP certification ensures that pharmaceutical products meet specific quality standards, assuring stakeholders of their efficacy. Regulatory Compliance: Adherence to GMP guidelines demonstrates a commitment to complying with industry regulations, enhancing trust among consumers and partners. Patient Safety: GMP practices prioritize patient safety by maintaining the highest standards in the manufacturing process. Global Recognition: GMP […]
How Israel-Hamas war will impact Indian pharma exports A Closer Look at the Implications of the Israel-Hamas Conflict on the Indian Pharmaceutical Industry In recent times, the escalating conflict between Israel and Hamas has generated substantial concerns and opportunities for the Indian pharmaceutical industry. The implications of this ongoing turmoil are not confined to the immediate region; they reverberate across international trade routes, causing stakeholders to assess the possible impact on drug shortages and export dynamics. In this comprehensive article, we delve into the multifaceted facets of this conflict and how it might shape the future of Indian pharma exports. Introduction India-Israel Pharma Trade Resilience Amidst Conflict The Israeli-Hamas conflict has set off alarm bells within the Indian pharmaceutical sector. While trade relations between India and Israel have traditionally been harmonious, the recent escalation in hostilities has raised questions about the resilience of this partnership. As a result, stakeholders are now exploring the potential repercussions on the pharmaceutical industry. Salil Kallianpur, an expert in the field, highlights the impending consequences, with a specific focus on countries like the UAE, Bahrain, Oman, Qatar, Egypt, and Saudi Arabia, all of which could potentially feel the ripples of this geopolitical conflict. In this […]
Mozambique, a nation with a complex history and a challenging present, is emerging as a potential player in the pharmaceutical business sector. In this article, we will delve into the country’s background, its pharmaceutical landscape, and the significant role played by Taj Pharmaceuticals in shaping this industry. Mozambique: A Historical Overview Pharmaceuticals Business in Mozambique Mozambique, located in Southeast Africa, gained its independence from Portugal in 1975. However, its journey to stability has been fraught with challenges. A devastating 16-year civil war that concluded in 1992 left the nation scarred, and tensions between the ruling Frelimo party and the former rebel movement Renamo persist to this day. Despite these hardships, Mozambique has shown signs of progress, particularly in its economy, which has benefited from the discovery of offshore gas reserves in 2011. A Closer Look at Mozambique Republic of Mozambique: Facts Capital: Maputo Area: 801,590 sq km Population: 31.6 million Languages: Portuguese, plus Makhuwa, Sena, Tsonga, Lomwe, Changana Life expectancy: 58 years (men) 64 years (women) Mozambique is currently under the leadership of President Filipe Nyusi, representing the Frelimo party. Despite his efforts to stabilize the country, an Islamist insurgency in the Cabo Delgado province has raised concerns about the […]
Ensuring product quality and safety is paramount. The World Health Organization (WHO) Good Manufacturing Practices (GMP) certification plays a pivotal role in achieving these objectives. In this article, we will delve into the significance of WHO GMP certification, particularly in the context of Taj Pharmaceuticals, a prominent player in the pharmaceutical industry. What is WHO GMP Certification? Regulatory Standards for Pharmaceuticals WHO GMP certification is a globally recognized quality assurance standard for the production and distribution of pharmaceuticals. It is issued by the World Health Organization, which is an agency of the United Nations responsible for international public health. This certification serves as a testament to a company’s commitment to producing high-quality, safe, and efficacious pharmaceutical products. Ensuring Product Quality One of the primary reasons for the significance of WHO GMP certification is its role in ensuring product quality. Taj Pharmaceuticals, like other certified companies, adheres to stringent quality control measures throughout the manufacturing process. This includes the use of quality raw materials, standardized production processes, and rigorous testing procedures. As a result, consumers can trust that the medications produced by Taj Pharmaceuticals meet the highest quality standards. Guaranteeing Safety Safety is a paramount concern in the pharmaceutical industry. WHO […]
Introduction: Innovation and Commitment In the intricate landscape of pharmaceuticals and biotechnology, the process of lyophilization, more commonly known as freeze-drying, stands as a pivotal method for preserving and extending the shelf life of delicate products. This meticulous procedure involves the removal of water content through a sequence of freezing and subsequent sublimation, resulting in a dry and stable end product. Key Stages of Lyophilization: Freezing: The initial stage is the critical process of lowering the temperature of the product, inducing the freezing of water within. This foundational step sets the groundwork for the subsequent phases. Primary Drying (Sublimation): During this stage, frozen water transforms directly from a solid (ice) to vapor through sublimation. This occurs under reduced pressure, allowing for the gentle removal of ice crystals. Secondary Drying (Desorption): Following primary drying, residual unfrozen water is eliminated. This is achieved by a slight increase in temperature and maintaining lower pressure, ensuring the removal of any remaining moisture. Advantages of Lyophilization: Preservation of Product Integrity: Lyophilization aids in maintaining the integrity of heat-sensitive products by avoiding the use of high temperatures during the drying process. Extended Shelf Life: By eliminating water, a critical factor in microbial growth and chemical degradation, […]
New Covid variant Eris symptoms appear a week before positive test? Know all about this ‘pre-Covid’ phenomenon In the ever-evolving landscape of the COVID-19 pandemic, new variants continue to emerge, each with its own set of characteristics and challenges. Among the latest variants to capture attention is the Eris variant, specifically EG.5. This variant has been spreading rapidly in various parts of the world, raising concerns and questions about its symptoms and detection. Understanding the Eris Variant EG.5, a sub-variant of the coronavirus, has garnered attention for its ability to spread quickly. However, experts have noted that the symptoms associated with this variant are relatively mild, and it doesn’t pose a significant threat in terms of severity. Despite this, EG.5 has been declared a variant of interest, and health authorities are closely monitoring its mutations. It’s worth noting that the rapid spread of EG.5 has led to some intriguing observations in the form of a ‘pre-Covid’ phenomenon. The ‘Pre-Covid’ Phenomenon What is the ‘pre-Covid’ phenomenon, and why are people reporting it in connection with EG.5 and other Omicron variants? To understand this, we need to delve into the incubation period of the virus. When a person contracts a virus like […]
Inflammatory bowel illnesses (IBD) like Crohn’s disease and ulcerative colitis are treated with mesalamine tablets, which provide patients with focused relief. These pills for oral use include mesalamine, an anti-inflammatory compound that works locally on the irritated gut lining. They relieve symptoms like gastrointestinal discomfort, diarrhea, and rectal bleeding by lowering inflammation. Mesalamine is used to treat ulcerative colitis Mesalamine tablets are available in a variety of forms, including delayed-release and extended-release, allowing for customized treatment strategies. In addition to providing patient comfort, this adaptability reduces systemic side effects. Mesalamine tablets are an excellent way to treat IBD, promoting remission and improving the quality of life for many people who are dealing with these chronic diseases. Mesalamine Tablets Manufacturers: Your Source of Quality and Trust Taj Pharmaceuticals Limited is a prominent name among Mesalamine Tablets Manufacturers in India. Their tablets are made with extreme care and adhere to strict pharmaceutical standards. Modern production facilities used by the company, along with strict quality control procedures, guarantee that each tablet contains the exact amount of mesalamine needed for therapeutic success. But why choose Mesalamine Tablets from Taj Pharmaceuticals Limited over other manufacturers? Let’s delve into the details. How do Mesalamine Tablets Work? […]
Dexamethasone is a type of corticosteroid medication manufactured by Taj Pharmaceuticals India. It is used in the treatment of many conditions, including COVID-19 respiratory side effects, rheumatic problems, a number of skin diseases, severe allergies, asthma, chronic obstructive lung disease, croup, brain swelling, eye pain following eye surgery, and along with antibiotics in tuberculosis. In adrenocortical insufficiency, it should be used together with a medication that has greater mineralocorticoid effects such as fludrocortisone. In preterm labor, it may be used to improve outcomes in the baby. It may be taken by mouth, as an injection into a muscle, or intravenously. The effects of dexamethasone are frequently seen within a day and last for about three days.
Unraveling Excellence in Iron Chelation Taj Pharmaceuticals stands tall as a distinguished Deferasirox Dispersible Tablets 500mg manufacturer in India. Let’s delve into the intricacies of this remarkable medication and why Taj Pharma is a name synonymous with quality and reliability. Treatment of Chronic Iron Overload – Deferasirox Tablets I. Understanding Deferasirox Dispersible Tablets 500mg A. Introduction to Deferasirox Championing the fight against iron overload, Deferasirox is a potent iron-chelating agent crucial for patients undergoing multiple blood transfusions. B. Therapeutic Indications Unveiling the medical tapestry, Deferasirox addresses ongoing high iron levels post-blood transfusions and offers a lifeline to those with non-transfusion-dependent thalassemia. II. Taj Pharmaceuticals: Pioneering Excellence A. The Taj Pharma Advantage Exploring the facets that make Taj Pharmaceuticals a frontrunner in Deferasirox Dispersible Tablets 500mg manufacturing. B. Quality Control Measures A deep dive into Taj Pharma’s stringent quality control, ensuring each tablet maintains an unwavering standard of excellence. III. Deferasirox Dispersible Tablets: Variants and Composition A. Generic Names and Composition Breaking down the different variants, from 100mg to 500mg, and their qualitative compositions. B. Qualitative and Quantitative Composition Understanding the meticulous composition details, emphasizing the commitment to consistency. IV. Caution, Schedule, and Proper Usage A. Cautionary Measures Guiding users on […]
Solving the ‘parking’ problem in the drug monopoly game Drug prices are too high. One reason is that brand-name drug firms delay generic entry. Another is that generic companies themselves delay entering the market. And they delay not only their entry but those of other generics as well. Congress is considering addressing this “parking” of generic exclusivity. One proposal, the BLOCKING Act of 2019, would not solve the problem. Another, the recently-introduced Expanding Access to Low-Cost Generics Act, would. The BLOCKING Act has received significant attention. Supported by the White House and included in legislation approved overwhelmingly by the Senate HELP Committee and House Energy & Commerce Committee, the Act provides that a generic that does not quickly enough receive FDA approval will lose exclusivity. It promises to address the “parking” of exclusivity. But it would not. Why? Because there’s no guarantee, a later generic will enter the market just because the first filer has lost exclusivity. These later generics might not be ready to launch or might be unwilling to challenge the first filer’s patents or launch “at-risk” (before a court decision). In addition to the BLOCKING Act not introducing competition, the first filer could lose exclusivity through no […]
A new peer-reviewed study by Dr Pierre Kory and colleagues on Ivermectin has been published in the American Journal of Therapeutics. Entitled “Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19“, it provides a new authoritative overview of the evidence to date and calls for the widely available drug to be “globally and systematically deployed in the prevention and treatment of COVID-19”. The study summarises the impressive evidence base for the use of Ivermectin. Ivermectin dispersible tablets 12mg Iverotaj D.T. 12 1. Since 2012, multiple in vitro studies have demonstrated that Ivermectin inhibits the replication of many viruses, including influenza, Zika, Dengue, and others.2. Ivermectin inhibits SARS-CoV-2 replication and binding to host tissue through several observed and proposed mechanisms.3. Ivermectin has potent anti-inflammatory properties with in vitro data demonstrating profound inhibition of both cytokine production and transcription of nuclear factor-κB (NF-κB), the most potent mediator of inflammation.4. Ivermectin significantly diminishes viral load and protects against organ damage in multiple animal models when infected with SARS-CoV-2 or similar coronaviruses.5. Ivermectin prevents transmission and development of COVID-19 disease in those exposed to infected patients.6. Ivermectin hastens recovery and prevents deterioration in patients with mild to […]
With a rich history and an unwavering commitment to quality and innovation, Taj Pharmaceuticals has firmly established itself as a global leader in the industry. In this comprehensive article, we delve deep into the vast product range offered by Taj Pharmaceuticals, shedding light on their pivotal role in healthcare. An Introduction to Taj Pharmaceuticals Taj Pharmaceuticals’ Extensive Product Range Taj Pharmaceuticals Limited, headquartered in the bustling city of Mumbai, India, is a renowned manufacturer and distributor of medicines. Their extensive product line encompasses a wide spectrum of healthcare solutions that cater to various medical needs. Let’s embark on a journey to discover the diverse categories of products that Taj Pharmaceuticals has to offer. Prescription Solutions At the core of Taj Pharmaceuticals’ product portfolio are their prescription solutions. These are medications formulated to address a myriad of health conditions. From common ailments to complex diseases, Taj Pharmaceuticals provides a range of effective prescription drugs that are trusted by healthcare professionals worldwide. Lifesaving Drugs When it comes to saving lives, Taj Pharmaceuticals steps up to the plate with a range of lifesaving drugs. These medications are designed to combat critical conditions, offering hope and healing to patients facing life-threatening illnesses. Anti-Cancer Drugs […]
Manufacturer of Oncology Products in Liquid, Lyophilized Injections, Tablets, and Capsules In the world of healthcare, the production of oncology products plays a pivotal role in combating cancer and improving the quality of life for patients. One company that stands out in this critical field is Taj Pharma. With a focus on manufacturing finished oncology formulations in various dosages, Taj Pharma has carved a niche for itself in the pharmaceutical industry. Taj Pharma: A Specialist in Oncology Formulations Taj Pharma is not just another pharmaceutical company; it’s a specialty pharmaceutical company dedicated to the expansion, manufacture, and marketing of quality finished dosages, particularly in the field of oncology. Let’s delve deeper into what makes Taj Pharma a standout player in this domain. Research & Development Excellence Taj Pharma boasts an impressive track record in research and development (R&D) with over three decades of experience in various sectors of the healthcare industry. This extensive knowledge base has enabled the company to stay at the forefront of innovation and produce cutting-edge oncology products. Strengthening Manufacturing Capabilities Recognizing the growing importance of the critical care segment, Taj Pharma has made substantial investments to enhance its manufacturing capabilities in the anti-cancer segment. This strategic […]
Ranitidine is a commonly prescribed medicine for countering acidity and is on the WHO’s Model List of Essential Medicines. Our drug Ranitidine Tablets are safe: Taj Pharmaceuticals Amid a raging controversy over commonly used heartburn drug Ranitidine, Mumbai-based Taj Pharmaceuticals Limited today said that its formulation drug is safe. The company said that the test results found that Taj Pharmaceuticals’ Ranitidine tablets was within the “acceptable limits” for the presence of a probable cancer causing substance. On 29th September 2019 US FDA had raised a global alarm over the presence of a probable cancer causing substance—NDMA or N-Niteosodimethylamine—in some Ranitidine medicines. The company is likely to continue Ranitidine drug sale, following the report. “The Company intends to provide additional updates in the next coming days, including potential recommencement,” it said in a statement. Taj Pharma Ranitidine Free of ALL NDMA / NDEA Impurities NDMA Risk Assessment Report is done in much more advanced for all potential APIs (Valsartan) on our ROS of Ranitidine Hydrochloride and analyzed few batches for NDMA content in Ranitidine HCL API by validated LC-MS/MS and GC-MS methods. As per our initial investigation and assessment report, it is found that the formation of NDMA in ROS of our […]
Introduction In the ever-evolving landscape of healthcare, the demand for safe, convenient, and innovative Intravenous (IV) solutions has seen a substantial surge. Taj Pharmaceuticals, a trailblazer in the pharmaceutical industry, is at the forefront of meeting this demand with its cutting-edge Large Volume Parenterals (LVP), including Non-PVC IV Bags and PVC IV bottles. Let’s delve into the extensive portfolio and revolutionary practices that Taj Pharma employs to address the growing needs of hospitals and outpatient facilities. Taj Pharma’s Large Volume Parenteral (LVP) Bag Line Aseptic Innovation for Enhanced Safety Innovating Healthcare with Large Volume Parenterals Taj Pharmaceuticals boasts a comprehensive LVP bag line, ranging from 50ml to 5000ml, with an impressive daily output of 24,000 units for the 500ml variant. The key highlight is the utilization of Aseptic Filling Aqueous technology, ensuring the highest standards of safety and purity. These LVP bags provide a versatile solution for various medical applications, catering to the intricate needs of healthcare professionals. Featured Products in Taj Pharma’s LVP Portfolio Diverse Range for Specialized Care Taj Pharma’s commitment to excellence is evident in its featured LVP products, designed to cater to specific medical requirements: Amino Acids Injections (IGMIN 5%, 7%, 8%): Available in 100ml, 250ml, […]
Introduction: Unveiling the Global Leader in Generics In the bustling landscape of pharmaceuticals, Taj Pharmaceuticals Limited emerges as a beacon of innovation and excellence. Headquartered in Mumbai, India, this pharmaceutical powerhouse boasts a product range exceeding 4600 compositions across all therapeutic categories. From prescription solutions to lifesaving drugs, veterinary products to CNS drugs, Taj Pharma stands at the forefront of the industry. Taj Pharmaceuticals: A Glimpse into the Product Spectrum Prescription Solutions for Diverse Ailments Standards with Taj Pharmaceuticals’ State-of-the-Art Quality Assurance Taj Pharmaceuticals addresses a myriad of health concerns, including anemia, anxiety disorders, cancer/oncology, ear infections, heart failure, hepatitis, HIV/AIDS, influenza, non-Hodgkin’s lymphoma, obesity, osteoporosis, Parkinson’s disease, pneumonia, transplantation, and common diseases. The company’s commitment to providing solutions for both common and critical health issues is evident in its extensive product lineup. Global Leadership in Generics Taj Pharmaceuticals has secured its position as a global leader in generics, ranking among India’s top ten pharmaceutical companies. Specializing in therapeutic areas such as cancer, virology, and transplantation, Taj Pharma’s impact reverberates worldwide. Integrated Healthcare Solutions: The Taj Pharma Approach The synergy of Taj Pharma’s generics and pharmaceutical businesses, combined with expertise in emerging genetic sciences, empowers the company to develop integrated […]
FDA Approves First Generic of Popular Blood Thinner The first generic versions of the powerful blood thinner Eliquis (apixaban) were approved by the U.S. Food and Drug Administration on Monday. Heparin Sodium Injection – Taj Pharmaceuticals “Today’s approvals of the first generics of apixaban are an example of how the FDA’s generic drug program improves access to lower-cost, safe and high-quality medicines,” Dr. Janet Woodcock, director of the FDA’s Center for Drug Evaluation and Research, said in an agency news release. “These approvals mark the first generic approvals of a direct oral anticoagulant,” Woodcock noted. “Direct oral anticoagulants [blood thinners] do not require repeated blood testing.” The two types of generic tablets were approved to reduce the risk of stroke and systemic clotting in the lungs of patients with non-valvular atrial fibrillation and for the prevention of deep vein thrombosis (DVT), which may lead to pulmonary embolism (lung clots), in patients who have had hip or knee replacement surgery. Atrial fibrillation is a heart rhythm disorder that raises the risk of blood clots. It is estimated that between almost 3 and 6 million Americans have atrial fibrillation, according to the U.S. Centers for Disease Control and Prevention. Many of these […]
We need a common regulator for pharma sector: FICCI chairman The pharmaceuticals and medical devices sector, which is currently governed by multiple regulators and ministries, needs a common regulator to simplify processes, said Federation of Indian Chambers of Commerce and Industry (FICCI) chairman here. Speaking at the sidelines of a seminar at the Vibrant Gujarat Global Summit here, Pankaj Patel, chairman and managing director of Cadila Healthcare and said that there was a need to simplify the regulatory processes governing the pharmaceutical sector. “A common regulator for the entire sector covering drugs, medical devices and others would simplify the processes and improve ease of doing business,” Patel who is also the chairman of FICCI said. He added that now there were multiple regulators including the National Pharmaceutical Pricing Authority (NPPA), the Central Drugs Standard Control Organisation (CDSCO) and others which come under the purview of various ministries. Department of Pharmaceuticals The NPPA which comes under the Department of Pharmaceuticals, Ministry of chemicals and fertilisers looks after drug pricing in the country and comes out with directives on the same. The CDSCO, in turn, has regulatory control over the import of drugs, approval of new drugs, clinical trials, among several others. […]
Biosimilar drugs are often confused with generic drugs. Both are marketed as cheaper versions of costly name-brand drugs and are designed to have the same clinical effect as their pricier counterparts. But biosimilar drugs and generic drugs are very different. Biosimilar drugs are often confused with generic drugs. Both are marketed as cheaper versions of costly name-brand drugs. Both are available when drug companies’ exclusive patents on expensive new drugs expire. And both are designed to have the same clinical effect as their pricier counterparts. But biosimilar drugs and generic drugs are very different, mainly because while generic drugs are identical to the original in chemical composition, biosimilar drugs are “highly similar,” but close enough in duplication to accomplish the same therapeutic and clinical result. Another key difference is that generics are copies of synthetic drugs, while biosimilars are modeled after drugs that use living organisms as important ingredients. But many experts hope the two will share a critical commonality and that, like generics, biosimilars will dramatically lower the cost of biologic drugs. “ Branded drugs are either synthetic, meaning they’re made from a chemical process, or biological, meaning they’re made from living sources. Synthetic branded drugs can be exactly […]
Taj Pharmaceuticals, a name synonymous with quality and innovation, emerges as the premier choice for those seeking excellence in pharmaceutical manufacturing. In this comprehensive guide, we delve into the world of third-party manufacturing in the pharmaceutical industry, explore the benefits of collaborating with third-party manufacturers, and shed light on why Taj Pharmaceuticals stands tall as one of the top third-party pharma manufacturers in India. An Intro to Third-Party Manufacturing Lifesaving Drugs and Innovation in India Third-party pharmaceutical manufacturing, often referred to as contract manufacturing, is a strategic partnership between a pharmaceutical company and a specialized manufacturing facility. In this arrangement, the pharmaceutical company outsources the production of its products to a third-party manufacturer, like Taj Pharmaceuticals. This outsourcing allows pharmaceutical companies to focus on research, development, marketing, and distribution while leaving the manufacturing process in expert hands. Benefits of Hiring Third-Party Manufacturers in Pharma Building Goodwill through Quality Selecting a third-party pharmaceutical company is a critical decision that can significantly impact the reputation and success of a pharmaceutical business. When chosen judiciously, it can lead to the production of high-quality products, thereby building goodwill among associates and customers alike. Taj Pharmaceuticals is committed to maintaining the highest standards of quality […]
Choirs are a secret lifeblood of our country. It’s unclear when and how we’ll ever sing together again. #CoronaVirus #CoronaPrevention #Safety #tajpharmaCorona #CoronaSpread #IndiaFightsCorona #CoronavirusOutbreakindia #CoronavirusPandemic #StaySafeStayHome #IndiaFightsCoronavirus
Taj Pharmaceuticals has consistently stood out for its dedication to research and development (R&D) initiatives. This article delves into the intricate details of Taj Pharmaceuticals’ R&D endeavors, shedding light on their innovations, accomplishments, and future prospects. Tell me more about Taj Pharmaceuticals’ research and development initiatives. Taj Pharmaceuticals has a rich history of pushing the boundaries of pharmaceutical innovation. Let’s explore their remarkable journey through their research and development initiatives. Pioneering Drug Discovery Quality Control and Quality Control Procedures At the heart of Taj Pharmaceuticals’ R&D efforts lies a relentless pursuit of pioneering drug discovery. Their team of experts tirelessly explores new compounds and formulations to address a wide range of medical conditions. Through cutting-edge research, they have developed groundbreaking treatments that have transformed the lives of countless patients. Collaborative Partnerships Taj Pharmaceuticals understands the importance of collaboration in the ever-evolving field of healthcare. They have forged strategic partnerships with leading research institutions and healthcare organizations worldwide. These collaborations allow them to leverage collective knowledge and resources to accelerate drug development and ensure the highest standards of safety and efficacy. Commitment to Quality Quality is non-negotiable for Taj Pharmaceuticals. Their R&D initiatives are underpinned by a commitment to producing safe […]
In the ever-evolving landscape of pharmaceuticals and healthcare, Zimbabwe has emerged as a pivotal player in recent years. With a history marked by political turbulence and economic challenges, this African nation has shown remarkable resilience and adaptability. In this comprehensive article, we delve into the pharmaceutical industry in Zimbabwe, with a particular focus on Taj Pharmaceuticals Limited, a global leader in generics, and its significant role in shaping the healthcare landscape of the country. The Zimbabwean Historical Tapestry Zimbabwe’s Pharmaceutical Sector The story of Zimbabwe is one of struggle and transformation. From the fight for independence to the complexities of land reform, this nation’s modern history is a narrative marked by resilience. Zimbabwe gained independence from British colonial rule in 1980, with President Robert Mugabe at the helm. For nearly four decades, Mugabe dominated the political scene, shaping the country’s destiny. However, his long reign was not without controversy, as Zimbabwe faced challenges such as severe droughts and a contentious land reform program. Republic of Zimbabwe: Key Facts Before delving further into the pharmaceutical landscape, let’s set the stage with some key facts about Zimbabwe: Capital: Harare Area: 390,757 sq km Population: 15.17 million Languages: Chibarwe, English, Kalanga, Koisan, Nambya, […]
Indian pharmaceutical market update Generic affordable alternatives are much more easily available India With around 1.3 billion residents, India is home to just a fraction fewer people than China, the world’s most populous nation. India is also developing fast, consistently posting annual gross domestic product (GDP) growth rates in the mid-to-high single digits since the turn of the millenium, and outpacing all other nations in 2018 with growth of 7.3%. The country’s GDP is now roughly equivalent to that of the UK in nominal terms. Adjusting for purchasing power differences it is the third largest, behind the USA and China. Despite these impressive figures, hundreds of millions of people live in poverty. India remains a developing nation, with a healthcare system to match. At around $30 billion, the country’s pharmaceutical market generates revenues roughly equivalent to those of the newly-enlarged Japanese drugmaker Takeda Pharmaceutical (TYO: 4502). The market for pharmaceutical products does not, therefore, move the needle for global drugmakers, but as it continues to grow in line with wider economic development, new opportunities will continue to emerge. “By 2020, the value of pharma products sold in the country is is expected to reach $55 billion.” By 2020, the value […]
Taj Pharma, a global pharmaceutical giant, leaves no room for compromise in ensuring that every new Full Automated system meets the required quality specifications. This validation process is conducted at every scale of manufacture across their seven interchangeable manufacturing plants worldwide. Understanding Process Validation in Pharmaceuticals Process Validation in Pharmaceuticals Formulations Manufacturing is a critical quality assurance procedure that ensures the consistency and reliability of pharmaceutical products. It involves a series of systematic and documented activities that confirm a manufacturing process consistently produces drugs that meet their predetermined quality specifications and standards. Quality Assurance Taj Pharmaceuticals Process validation is an integral part of the pharmaceutical industry’s quality assurance. It’s essential to guarantee that every medication produced is of the highest quality, safe for consumption, and effective in treating the intended medical condition. Consistency and Reliability The key objective of process validation is to demonstrate that the manufacturing process is consistent and reliable. This means that each batch of a pharmaceutical product, whether it’s a tablet, capsule, liquid, or any other form, should be identical in terms of its composition, quality, and performance. Stages of Validation Process validation is typically conducted in three stages: Prospective Validation: This stage occurs before the […]
The symptoms of frontotemporal, or early onset, dementia can appear as early as age 40. Have researchers found a new way to treat this condition using antibiotics?
Nigeria, the most populous country in Africa, is a nation of rich history and diverse cultures. In this article, we delve into the multifaceted landscape of Nigeria, exploring its political history, demographic diversity, and the pharmaceutical industry, with a focus on Taj Pharmaceuticals’ role in this dynamic market. Nigeria: A Historical Perspective Nigeria Country Profile Nigeria’s modern state owes its present territorial shape to 19th-century British colonialization. This diverse nation, inhabited by over 250 ethnic groups speaking more than 500 distinct languages, achieved independence in 1960. However, its journey to political stability was marked by a civil war from 1967 to 1970, when the breakaway state of Biafra declared independence. The political landscape of Nigeria saw a succession of military dictatorships and civilian governments until the establishment of a stable democracy in the 1999 presidential elections. This diverse ethnic and cultural nation has faced challenges in preventing ethnic and religious divisions, with separatist aspirations gaining traction. Nigeria’s Complex Security Challenges Nigeria’s security landscape is multifaceted and poses significant challenges to the federal government. These challenges include: Jihadist Insurgency in the North: The northern region faces a persistent jihadist insurgency. Herder-Farmer Clashes: Conflicts between animal herders and farmers over water and […]
Rwanda’s Pharmaceutical Industry: A Booming Sector in East-Central Africa In the heart of East-Central Africa, Rwanda is emerging as a dynamic player in the global pharmaceutical industry. This small landlocked nation, known for its tumultuous history, is now making significant strides in the healthcare sector, with a particular focus on pharmaceuticals. In this comprehensive article, we delve into the thriving pharmaceutical business landscape in Rwanda, exploring key players, challenges, and opportunities in the sector. Rwanda’s Remarkable Resilience Rwanda Country Profile Rwanda, a country marred by ethnic strife and the tragic genocide in the mid-1990s, has shown remarkable resilience in rebuilding its nation. The government’s efforts have not only led to political stability but also paved the way for economic development. Among Rwanda’s main exports, coffee and tea production stand out. These industries have not only contributed to the country’s GDP but have also played a pivotal role in reducing poverty and inequality. A Snapshot of Rwanda Before delving deeper into Rwanda’s pharmaceutical sector, let’s take a quick look at some key facts about this vibrant nation: Capital: Kigali Area: 26,338 sq km Population: 13.8 million Languages: Kinyarwanda, French, English, Swahili Life Expectancy: 64 years (men), 69 years (women) At the […]
Tell me more about Taj Pharmaceuticals’ Global Partnerships In today’s interconnected world, global partnerships are essential for businesses looking to expand their reach and impact. Taj Pharmaceuticals, a leading player in the pharmaceutical industry, has established a significant presence in various regions around the globe. In this comprehensive article, we’ll delve into Taj Pharmaceuticals’ global partnerships, focusing on regions like Russia and CIS Countries, GCC/Middle East Countries, African Countries, Southeast Asia, and other Asian Countries. Exploring Russia and CIS Countries Partnership Regulatory Standards for Pharmaceuticals Taj Pharmaceuticals has forged strong partnerships with countries in the Russia and CIS (Commonwealth of Independent States) region. These countries include Azerbaijan, Armenia, Belarus, Georgia, Kazakhstan, Kyrgyzstan, Moldova, Russia, Tajikistan, Turkmenistan, Uzbekistan, and Ukraine. Collaborative Efforts for Healthcare Advancements Taj Pharmaceuticals’ collaboration with Russia and CIS Countries aims to enhance healthcare access and provide cutting-edge pharmaceutical solutions to these nations. The partnership involves knowledge sharing, technology transfer, and joint research initiatives. Addressing Unique Healthcare Challenges Each country in the region faces its own healthcare challenges. Taj Pharmaceuticals tailors its partnerships to address specific needs, be it combatting infectious diseases, improving maternal and child health, or advancing medical research. Localized Support and Outreach To ensure effective […]
Taj Pharmaceuticals Limited: Pioneering Oncology Formulation with Unmatched Excellence Unveiling Taj Pharmaceuticals Limited’s Dedication to Oncology Formulation Development In the era of pharmaceutical excellence, Taj Pharmaceuticals Limited stands as a beacon of innovation and commitment, particularly in the field of oncology formulation development. This article delves into the company’s journey, its major successes, and its notable contributions to the pharmaceutical industry. A Glimpse into Taj Pharmaceuticals Limited Taj Pharmaceuticals Redefining Excellence in Oncology Formulation Taj Pharmaceuticals Limited, headquartered in Mumbai, India, is an integrated and research-based pharmaceutical company with a sharp focus on super specialty products. The company’s Oncology Division has emerged as a dedicated force in chemotherapeutic formulations, offering a diverse array of innovative solutions and therapies. Trusted globally by healthcare professionals and patients alike, Taj Pharma is renowned for its unwavering commitment to quality. Leadership and Vision Taj Pharmaceuticals Limited is not just a pharmaceutical company; it embodies sheer grit, a zeal to innovate, and a commitment to producing standout products. Dr. Ranvir Kumar Singh, Mr. Abhishek Singh, CEO Mrs. Priyanka Singh, the driving forces behind the company, envisioned a future where success wasn’t solely measured by numbers. This vision has propelled Taj Pharma to become one of […]
Proton pump inhibitors (PPIs) constitute a crucial class of medications addressing an array of stomach acid-related conditions. This comprehensive overview delves into PPIs’ indications, mechanisms, contraindications, and vital aspects pivotal for an interprofessional approach in managing acid-related disorders. Objectives: Unraveling PPI Mechanism: Understand the intricate mechanism through which PPIs decrease stomach acid secretion. Adverse Effects Insight: Explore potential adverse effects associated with PPI use. Optimal Monitoring: Delve into the appropriate monitoring strategies for patients utilizing PPIs. Interprofessional Collaboration: Outline collaborative strategies for healthcare teams to enhance PPI outcomes. Indications: PPIs, renowned for acid-related disorder management, are indispensable in treating various conditions, including: Esophagitis Non-erosive reflux disease Peptic ulcer disease Preventing nonsteroidal anti-inflammatory drug-induced ulcers Zollinger-Ellison Syndrome Helicobacter pylori infections (triple therapy regimen) The FDA-approved PPIs as of 2015 encompass Omeprazole, Esomeprazole, Lansoprazole, Dexlansoprazole, Pantoprazole, and Rabeprazole. Furthermore, PPIs find utility in pediatric care for GERD and eosinophilic esophagitis treatment. Mechanism of Action: PPIs curtail stomach acid secretion by targeting parietal cells via the H+/K+ ATPase enzyme inhibition. Interestingly, PPIs function as prodrugs, requiring acid-catalyzed cleavage in parietal cells for activation. CYP2C19 predominantly degrades PPIs, with variations affecting drug response. Understanding metabolism aids tailored dosing for different ethnicities and ages. Administration […]
Pharmaceutical pricing authority discussed issue in 2019, show documents The shortage of key leprosy drug clofazimine in the country is not of recent origin, but a long-standing problem not properly addressed by the Union government, official documents show. clofazimine Minutes of a meeting of the National Pharmaceutical Pricing Authority (NPPA) under the Drug Pricing Control Order (DPCO), 2013 dated October 30, 2019 say Abbott Healthcare Private Limited has been directed not to discontinue the production of the drug as it could lead to shortages. DPCO is an order under the Essential Commodities Act, 1955 that enables the Union government to control and fix the prices of essential medicines and their formulations. The meeting discussed the Form-IV submitted by the company for the discontinuation of scheduled drug formulations Hansepran 50 mg (Clofazimine Capsule 50mg) and Hansepran 100 mg (Clofazimine Capsule 100mg) under para 21(2) of DPCO. “[The] authority considered the request of M/s Abbott Healthcare Pvt. Ltd and noted that [the] company has near monopoly (around 98% market share) for these critical medicines for leprosy and a sudden discontinuation could lead to shortages. It was therefore decided to direct the company to issue a public notice and continue production/import/sale for a […]
Meta-analysis finds some ivermectin benefits in COVID-19 patient An analysis published in Open Forum Infectious Diseases found a 56% reduced risk of mortality for COVID-19 patients taking the anti-parasitic drug ivermectin compared to standard of care or another therapy. The study pulled data from 24 randomized trials involving 3,328 patients with moderate to severe COVID-19. Ivermectin tablets USP 12 mg (Iverotaj 12) The study also found that ivermectin was “associated with reduced inflammatory markers” and quicker viral clearance. Ivermectin, a widely available inexpensive drug used to treat worm and scabies infections in humans and animals, has emerged as a COVID-19 treatment in several parts of the world. Its use, however, has been controversial. WHO has counseled against its use as a COVID-19 treatment outside of clinical trials. And Merck, an ivermectin manufacturer, released a statement in February saying there was no scientific evidence to support the use of ivermectin for COVID-19. A study recently published in the American Journal of Therapeutics also found some benefits for ivermectin in treating COVID-19 with moderate-certainty evidence. The data from the study published in Open Forum Infectious Diseases is unlikely to convince skeptics. Nine of the studies involved in the meta-analysis were preprints. Another […]
{Taj Pharmaceuticals} Manufacturing Drug that prevents half of [Breast cancers growth]: A drug that halves a woman’s risk of breast cancer continues to work long after they stop taking it, say researchers. Anastrozole blocks the production of the hormone oestrogen, which fuels the growth of many breast cancers. It is already available on the NHS, but researchers at Queen Mary University of London said only a tenth of eligible women were receiving it. Cancer Research UK said the findings were reassuring. Who can take it? Anastrozole can be given only after the menopause because it cannot suppress oestrogen in younger women. It is already used as a treatment once breast cancer has been discovered, but now trials are focusing on preventing cancers emerging in the first place. Previous research, has shown anastrozole halves the risk of breast cancer during the five years women took the drug. But now, trials on 3,864 women show those taking it had 49% fewer breast cancers, even seven years after stopping treatment. In other words – the benefit lasts. The findings have been published in the Lancet and presented at the San Antonio Breast Cancer Symposium in Texas. “Breast cancer is the commonest cancer in […]
A Look at How Taj Pharmaceuticals Complies In the ever-evolving landscape of pharmaceuticals, adherence to stringent regulatory standards is paramount. These standards serve as a cornerstone for ensuring the safety, efficacy, and quality of pharmaceutical products. This article delves into the common regulatory standards that govern the pharmaceutical industry and sheds light on how Taj Pharmaceuticals diligently follows these regulations. Understanding Pharmaceutical Regulatory Standards What are Pharmaceutical Regulatory Standards? Dosage Forms Research Development Pharmaceutical regulatory standards encompass a set of rules, guidelines, and requirements established by governmental bodies and international organizations. These standards aim to maintain the highest levels of safety, quality, and efficacy in the development, manufacturing, and distribution of pharmaceutical products. Role of Regulatory Bodies Regulatory bodies such as the Food and Drug Administration (FDA) in the United States and the European Medicines Agency (EMA) in Europe play a pivotal role in setting and enforcing these standards. They scrutinize every aspect of pharmaceutical development, from preclinical trials to post-market surveillance. Common Pharmaceutical Regulatory Standards Good Manufacturing Practices (GMP) GMP standards ensure that pharmaceutical manufacturers maintain consistently high-quality production processes. These guidelines cover everything from facility cleanliness to product testing, ensuring that medications are safe and effective. Good Clinical […]
Taj Pharmaceuticals Limited: Pioneering Excellence in Betalactam Dry Powder Injectable Manufacturing Unveiling Taj Pharmaceuticals Limited’s State-of-the-Art Facility In the realm of pharmaceuticals, Taj Pharmaceuticals Limited stands tall as a leading manufacturer and exporter of Betalactam Dry Powder Injectable. With its cutting-edge manufacturing facility nestled in India, the company has etched its name in the global pharmaceutical landscape. PICs WHO-GMP Accredited Company Our State-of-the-Art Manufacturing Facility Compliance with the Newest Norms At Taj Pharmaceuticals Limited, our manufacturing facility is a testament to innovation and adherence to the latest norms. We take pride in constructing a facility that aligns with the most recent industry standards, ensuring the production of pharmaceuticals that meet and exceed global benchmarks. International Regulatory Approvals Our commitment to quality is reflected in the approval of our facility by several international drug regulatory authorities, including the Philippines. We operate under the stringent guidelines of WHO cGMP and PIC/s norms, assuring the highest quality standards in the production of Betalactam Dry Powder Injectable. Exploring the Product Portfolio: A Gateway to Mutual Business Growth Ceftriaxone Sodium Injection 1000mg/500mg/250mg/2000mg/3000mg variants catering to diverse medical needs. Ceftriaxone Sodium + Sulbactam Sodium Inj. 1500mg/750mg/375mg/4500mg formulations, blending efficacy with versatility. Ceftriaxone Sodium + Tazobactam Sodium […]
‘A combination of approved Ivermectin, Zinc and Doxycycline has shown positive results for COVID-19 and should be considered immediately to fight the pandemic’ Taj Covi Safe Kit Contains Zinc Acetate 50 mg, Doxycycline 100 mg & Ivermectin 12 mg Dispersible Tablets Australia’s The Centre for Digestive Disease (CDD) Medical Director Professor Thomas Borody MB, BS, BSc(Med), MD, PhD, DSc, FRACP,FACP,FACG, AGAF, says FDA and TGA approved Ivermectin which he uses regularly in his hospital, has shown positive results for COVID-19 and should be considered immediately to fight the pandemic. Ivermectin was discovered in the 1970s and is on the World Health Organization (WHO) list of essential medicines. Professor Borody has used the same methodology with the COVID-19 Ivermectin Triple Therapy as he used when he developed the world’s first cure for peptic ulcers saving millions of lives around the globe. He says this combination of 3 approved “off the shelf” drugs could be the answer to Australia’s COVID-19 crisis. “If nothing else, make it available in aged care homes immediately. Our elderly are at the highest risk and this is a very safe option especially when we have nothing else except ventilators. Also, our frontline workers deserve more protection with a preventative […]
Elevating Standards in Manufacturing Ensuring Excellence in Quality Management Systems for Unmatched Product Quality In the dynamic landscape of pharmaceutical and manufacturing industries, adherence to stringent quality and regulatory standards is paramount. This article delves into the salient features of our Quality Management Systems, emphasizing an integrated approach towards quality control, quality assurance, production, and regulatory affairs. The Pillars of Quality Management Systems Quality management is the linchpin of our operations, ensuring that each product that leaves our facility meets the highest standards. Let’s explore the key elements that underscore the robustness of our Quality Management Systems. Integrated Approach for Seamless Quality Assurance EU-GMP PICs Certification Taj Pharma’s Global Commitment to Quality Our commitment to quality begins with an integrated approach that intertwines quality control, quality assurance, production, and regulatory affairs. This holistic strategy ensures that every step of the manufacturing process aligns with the highest quality standards set by regulatory authorities. State-of-the-Art Analytical Instrumentation At each manufacturing step, we employ state-of-the-art analytical instrumentation to monitor product quality meticulously. This advanced technology allows us to maintain precision and accuracy, ensuring that our products consistently meet or exceed industry standards. Continuous Improvement as a Quality Imperative Our dedication to quality extends […]
You should check the registration number of the online pharmacy and cross-check it at the website of the regulatory body. The names of fake online drug stores will be blacklisted by the regulatory body. You should check whether an online pharmacy asks for a prescription before dispatching your medicines.
I. Introduction A. Brief overview of Taj Pharma B. Headquarters and specialization II. Formulation Development A. In-house process equipment B. Dosage forms offered 1. Injectable 2. Oral Solids 3. Oral Liquids 4. Semisolids III. Oral Solids A. R&D support for tablets B. Development of capsules C. Powder for oral solutions/suspensions IV. Injectable Capabilities A. Development of aqueous and non-aqueous injections B. Ophthalmic solutions C. Lyophilized products V. Nutraceuticals A. Impressive group available for tech transfer B. Out-licensing opportunities VI. Achievements and Track Record A. Products filed with USFDA B. Successful approvals and commercialization VII. Collaborations A. Partnerships with renowned pharma companies B. Highlight of successful collaborations VIII. Essential Services A. Dossier Development B. Tech Transfer C. Commercial Supply D. BA/BE, CT, and Nutraceutical product supply IX. Invitation to Explore Opportunities A. Call to action for potential partnerships B. Eagerness to discuss possibilities X. Conclusion A. Expressing confidence in collaboration B. Gratitude for considering Taj Pharma XI. FAQs A. Frequently asked questions about Taj Pharma and its services Taj Pharma: Revolutionizing Pharmaceutical Development Pharmaceutical Manufacturing Partner In the bustling world of pharmaceuticals, one name stands out for its commitment to excellence and innovation – Taj Pharma. Headquartered in Mumbai, Taj Pharma, […]
The Future of the Pharmaceutical Industry in India: Navigating Challenges and Opportunities The COVID-19 pandemic has not only been a global health crisis but has also unleashed economic challenges across various industries. This tumultuous period has particularly emphasized the urgency for India to achieve self-reliance, a narrative captured by the ‘Atmanirbhar Bharat’ initiative. However, the ongoing pandemic has brought to light the vulnerabilities of India’s pharmaceutical sector, especially in terms of overdependence on imports for crucial medical supplies. Overdependencies on Global Markets India has earned its reputation as a leader in the global pharmaceutical landscape, boasting the largest number of US-FDA compliant Pharma plants and a significant share of WHO-GMP approved facilities. Despite these accomplishments, the Indian pharmaceutical industry ranks as the 14th largest globally, with exports contributing only 3.5% to total pharmaceutical exports. Pharmaceutical Industry in India The sector excelled in formulations and indigenous medicines, but gradual liberalization led to an influx of imports, particularly from China. Approximately 70% of India’s pharmaceutical requirements depend on Chinese imports, especially for Active Pharmaceutical Ingredients (APIs), the essential components for drug formulations. China’s cost-effective technologies, large-scale manufacturing, and supportive government policies made it a dominant force in API production, causing the shutdown […]
A Boon for Qatar’s Healthcare Industry In recent years, the state of Qatar has witnessed an unprecedented growth in its population. However, with this demographic surge comes a formidable challenge – the rise of chronic health issues such as obesity, diabetes, and cardiovascular diseases. In this article, we delve into the reasons why Pharmaceutical Export from India to Qatar is the solution to this growing healthcare crisis. Rising Healthcare Demand in Qatar Qatar, Doha Pharmaceuticals Business from India Qatar’s healthcare system is under immense pressure due to the escalating prevalence of chronic diseases, exacerbated by the rapidly growing population. The demand for pharmaceuticals to treat these conditions has reached unprecedented levels. Unfortunately, the small size of the pharmaceutical market in Qatar, coupled with the increasing expenditure required for healthcare operations, makes it challenging for the nation to meet its healthcare needs independently. The Role of Indian Pharmaceutical Companies Indian pharmaceutical companies have emerged as crucial players in addressing Qatar’s pharmaceutical demands. Companies like Taj Pharma have positioned themselves as leaders in this endeavor, thanks to their readily available raw materials, a skilled workforce, and state-of-the-art machinery. These factors enable Indian pharmaceutical companies to export high-quality pharmaceutical products to Qatar at […]
New evidence supports inverse association between cancer and Alzheimer Among patients with a history of cancer, risk of Alzheimer disease (AD) might be lower: a study published in JAMA Network Open showed that elderly cancer patients had modestly higher memory function and slower memory decline both before and after their diagnosis compared with similarly aged individuals who remained cancer free. This result suggests that the risk of cancer may be lower among patients with AD, and that cancer survivors may have a lower risk of developing AD than people who did not develop any tumour. The inverse association between cancer and AD or other neurodegenerative diseases has been already described extensively in the literature, however evidence remains scarce on the long-term cognitive trajectories, as Monica Ospina-Romero, MD, from the department of epidemiology and biostatistics at University of California, San Francisco, and colleagues wrote. To compare long-term memory trajectories before and after cancer with those memory trajectories of individuals cancer free, researchers conducted a population-based cohort study which included over 14.500 U.S. adults from the Health and Retirement Study. Biennially, they assessed participants from 1998 to 2014 to determine composite memory score and compare the rates of memory change. Of 14,583 participants included […]
FDA Allows for a New Generic Valsartan Approval comes in response to ARB shortage The FDA approved a new generic for valsartan tablets after a priority review, according to an agency announcement. This valsartan product is made by Indian company. Approval comes in the middle of a valsartan shortage stemming from multiple rounds of recalls of the angiotensin receptor blocker (ARB). Products were taken off the shelves starting last year in response to findings of potentially carcinogenic impurities, including N-nitrosodimethylamine (NDMA) and N-nitrosodiethylamine (NDEA), in numerous lots of generics. “So to address the public health consequences of these shortages, we’ve prioritized the review of generic applications for these valsartan products,” said FDA Commissioner Scott Gottlieb, MD, in a statement. “For this approval, the FDA evaluated the company’s manufacturing processes and also made sure they used appropriate testing methods to demonstrate that the valsartan product approved today does not contain NDMA or NDEA,” the statement continued. “The FDA’s assessment of the manufacturing processes for the product determined that there is no known risk for the formation of other nitrosamine impurities.” “We hope that today’s approval of this new generic will help reduce the valsartan shortage, and we remain committed to implementing measures to […]
Palestine emerges as a unique and challenging market, shaped by complex political dynamics and the ever-evolving healthcare landscape. This article will delve into the pharmaceutical business in Palestine, offering insights, statistics, and key players in this niche sector. The Palestinian Conundrum Palestine Country Profile Palestine, officially the State of Palestine, is a nation located in West Asia. The region has been the epicenter of a long-standing conflict between Palestinians and Israel. The Palestinian territory comprises the West Bank and the Gaza Strip, with both areas being under Israeli occupation since 1967. This political instability has profound effects on various aspects of life in Palestine, including the pharmaceutical sector. A Glimpse into the Demographics The Palestinian population is split between those residing in historic Palestine and a widespread diaspora, primarily in neighboring Arab countries. The Palestinian population in the West Bank and eastern Jerusalem has been living under Israeli occupation for decades, while Israel’s settlements in the West Bank have further complicated the situation. These settlements, home to 500,000 people, are considered illegal under international law, although Israel disputes this. The Thorny Issue of Palestinian Refugees Another contentious issue revolves around the status of Palestinian refugees and their right to return […]
Half of pediatric cancers undiagnosed and untreated worldwide Nearly one in two children with cancer are never diagnosed and may die untreated, according to a a new model proposed in a study published in The Lancet Oncology by Zachary Ward and colleagues from Harvard University T.H. Chan School of Public Health. In fact, the model estimates that there were 397.000 childhood cancer cases globally in 2015, while only 224,000 had been previously recorded as diagnosed that year, leading ultimately the researchers to say that over 43% of childhood cancer cases were undiagnosed. But there was substantial regional variation: it ranges from 3% in both Western Europe (120 undiagnosed cases out of 4,300 total new cases) and North America (300 of 10,900 cases), to 57% (43,000 of 76,000 new cases) in Western Africa. With such path, at current levels of health system performances, If no improvements are made, the study authors estimated that nearly three million out of 6.7 million total cases will be missed between 2015 and 2030. Accounting for underestimation is vital: accurate estimates of incidence are important for policy makers, however, many countries do not have cancer registries that quantify that incidence (and often even if they do […]
In the ever-evolving landscape of pharmaceutical innovation, one name shines brightly as a true luminary – Taj Pharmaceuticals. With an unwavering commitment to excellence, Taj Pharma India has carved an indelible niche for itself as a global leader in the production of Cephalosporin dry powder injections. Within the confines of its cutting-edge manufacturing facility, Taj Pharma weaves together a symphony of science, technology, and dedication to craft pharmaceutical products that redefine industry standards. Crafting Excellence in β-Lactam Domains Taj Pharmaceuticals’ ascendancy in the pharmaceutical realm is underpinned by its β-lactam division, a realm where craftsmanship meets precision. The coveted certification for current Good Manufacturing Practices (cGMP) serves as a testament to the company’s resolute commitment to maintaining the highest levels of quality and regulatory compliance. The global footprint of Taj Pharma echoes its resounding success, as its products traverse borders and oceans, reaching far-flung corners of the world. Diving deeper into the heart of Taj Pharmaceuticals’ offerings, the spotlight falls on the distinguished Bactram (β-lactam Products). This esteemed collection of pharmaceutical marvels encompasses a spectrum of products, each a testament to the company’s unwavering pursuit of excellence. The Elegance of Ceftriaxone Sodium Injections Ceftriaxone Sodium Inj 1000mg/500mg/250mg/2000mg/3000mg Ceftriaxone Sodium + […]
Global Call To Action on Familial Hypercholesterolemia: Aims to Improve Diagnosis and Treatment Worldwide The FH Foundation and the World Heart Federation announced today a Global Call to Action on familial hypercholesterolemia (FH), a vastly under-recognized and poorly managed public health concern. Published in JAMA Cardiology and authored by a global panel of scientific experts, advocacy leaders, public health officials, and individuals with FH from 40 countries, the report notes glaring gaps in screening and guideline-based care for FH, the most common cause of early and aggressive heart disease. FH is an inherited metabolic disorder found in all races and ethnicities and impacts 34 million people worldwide. FH causes high LDL-cholesterol from birth and should be diagnosed and treated within the first two decades of life. Left untreated, individuals with FH have a 20-times higher risk of illness and death from cardiovascular disease (CVD). However, if diagnosed and treated, heart attacks, strokes and the need for surgery can be prevented. The international coalition was convened by the FH Foundation and World Heart Federation to reexamine and update key recommendations issued by the World Health Organization (WHO) in their report on Familial Hypercholesterolemia in 1998. In the 20 years since that report, […]
Taj Pharmaceuticals Biotechnological Division has announced the research in order to create an mRNA vaccine against SARS-COV-2 (coronavirus). Development will be based on previous pipelines for mRNA-oncovaccines creation: an area where the company has a great expertise. The first animal studies are scheduled for the end of April.
Taj Pharma India | Taj Pharmaceuticals India | Taj Pharma | Taj Pharma Hyderabad | Taj Pharma Mumbai | Taj Pharma Bombay | Taj Pharma News | Taj Pharma India News | Taj Pharma Updates | Taj Pharma Products | Taj Pharmaceuticals Products | Taj Pharma Owner | Taj Pharma CEO | Taj Pharmaceuticals CEO | Taj Pharma Jobs | Taj Pharma Vacancy | Taj Pharma Review | Taj Pharma Director
In the realm of pharmaceutical manufacturing, adherence to Good Manufacturing Practices (GMP) regulations is paramount. Taj Pharmaceuticals has consistently demonstrated an unwavering commitment to these stringent standards, setting a benchmark in the industry. In this article, we delve into the comprehensive approach adopted by Taj Pharmaceuticals Manufacturing Plants in ensuring strict compliance with GMP regulations. The Foundation of GMP Understanding GMP Regulations Taj Pharmaceuticals’ Global Partnerships GMP regulations are a set of guidelines and principles established by regulatory authorities to ensure the consistent production of safe, effective, and high-quality pharmaceutical products. These regulations cover every aspect of the manufacturing process, from facility design to product testing, packaging, and distribution. The Significance of GMP Compliance Compliance with GMP regulations is not merely a legal requirement; it is the foundation of pharmaceutical quality assurance. It encompasses the following key areas: Quality Control: GMP ensures that each pharmaceutical product consistently meets quality standards, reducing the risk of contamination and defects. Patient Safety: Strict adherence to GMP regulations safeguards patient health by minimizing the possibility of substandard or unsafe medicines reaching the market. Market Reputation: GMP compliance is a testament to a company’s commitment to excellence, enhancing its reputation and trustworthiness in the industry. […]
We Taj Pharmaceuticals are in the midst of challenging times, brought upon us due to the unimaginable spread of COVID-19. As we grapple with this difficult and ever evolving situation, we wanted to reach out to make sure that you are doing okay and in case you needed any help. It is hard to think of a business that is not impacted by this pandemic, the effects of which we will all continue to feel for a long time. Considering the current situation across the globe wherein everyone is trying their best to tackle the Coronavirus pandemic, we understand that we aren’t insulated from any uncertainties too. We, as an organisation, are doing our bit to ensure the safety and security of our employees, partners, etc. while ensuring that the work isn’t hampered. coronavirus As a firm, we have always placed the highest emphasis on delivering quality generics to all our clients, consistently. I want to take this opportunity to assure you that our professional commitments continue to occupy an important place for all of us at Taj Pharmaceuticals even as we steer our way through the crisis. Our Values of Care and Working Together come to fore in difficult […]
{Taj Pharma Cancer Awareness Initiative} Unraveling the Link: Gut Bacterium’s Genetic ‘Fingerprints’ in Bowel Cancer Introduction: In a groundbreaking revelation, researchers from The Netherlands, the UK, France, and the USA, funded by a £20 million Cancer Research UK Grand Challenge award, have uncovered a potential link between a common gut bacterium and bowel cancer. The findings, published in Nature, shed light on how a toxin released by a strain of E. coli leaves unique ‘fingerprints’ of DNA damage on gut cells, directly connecting it to genetic changes driving cancer development. The Role of Colibactin: Colibactin and Bowel Cancer Decoding the Genetic Connection The focus of this study was on a specific strain of E. coli that produces a toxin known as colibactin. This toxin, found more frequently in the stool samples of individuals with bowel cancer, was suspected of causing DNA damage. To validate this, scientists utilized human intestinal organoids, miniature replicas of the gut, and exposed them to colibactin-producing E. coli. The results revealed a significant increase in DNA damage compared to organoids exposed to regular E. coli. Distinctive DNA ‘Fingerprints’: Remarkably, the DNA damage caused by colibactin exhibited specific patterns akin to fingerprints. This unique signature was then […]
Ranitidine, a widely prescribed medication for combating acidity, has long held a place on the World Health Organization’s Model List of Essential Medicines. Amidst recent concerns and controversies surrounding the commonly used heartburn drug Ranitidine, Mumbai-based Taj Pharmaceuticals Limited has asserted the safety of its formulation. This article delves into the details surrounding Taj Pharmaceuticals’ Ranitidine tablets and their commitment to ensuring safety. The Ranitidine Controversy On September 29, 2019, the U.S. Food and Drug Administration (FDA) raised a global alarm regarding the presence of a probable cancer-causing substance known as NDMA or N-Niteosodimethylamine in some Ranitidine medicines. This revelation sent shockwaves through the pharmaceutical industry, prompting extensive investigations and safety assessments. Taj Pharmaceuticals’ Assurance Ranitidine Tablets 150mg Taj Pharmaceuticals Limited, in response to these concerns, conducted rigorous tests to determine the safety of their Ranitidine tablets. The results of these tests found that Taj Pharmaceuticals’ Ranitidine tablets fell within the “acceptable limits” for the presence of NDMA, the aforementioned cancer-causing substance. This assurance from Taj Pharmaceuticals is a significant development for patients and healthcare professionals alike. Resumption of Ranitidine Sales Following the reassuring test results, Taj Pharmaceuticals is poised to continue the sale of Ranitidine drugs. In a statement, […]
Radiation therapy | Immunotherapy | Hormone therapy | Targeted therapy | Making a decision | Outlook | Takeaway Doctors use chemotherapy either as a first-line therapy or in combination with other treatments, such as surgery. If chemotherapy does not work, a person may need to consider other treatment options.
When it comes to Ivermectin Tablet manufacturers, Taj Pharmaceuticals Limited stands out as a reputable and trusted name. This article delves into the world of Ivermectin Tablets, their significance, and why Taj Pharmaceuticals is the top choice for those seeking quality healthcare solutions. Understanding Ivermectin Tablet Ivermectin Tablet contains the active ingredient, Ivermectin, classified under the group of antiparasitic agents. This potent medication has found extensive use in treating a wide array of parasitic infections affecting both humans and animals. Its mechanism of action targets the parasites’ neurological system, inducing paralysis and eventual demise of the parasites. Why Choose Taj Pharmaceuticals Limited? Commitment to Quality and Safety Ivermectin 12mg Tablets (Iverotaj 12) Taj Pharmaceuticals Limited has solidified its position as a top Ivermectin Tablet manufacturer through its unwavering commitment to producing safe and effective pharmaceuticals. Their dedication to delivering trustworthy healthcare solutions is underpinned by a rich history of research, development, and manufacturing excellence. When you choose Taj Pharmaceuticals, you are assured of the authenticity and effectiveness of their Ivermectin Tablet, backed by their sterling reputation in the pharmaceutical industry. Global Recognition Taj Pharmaceuticals Limited is not just a local player; it’s a name recognized and respected by medical professionals […]
Are you up to date on recent developments in cystic fibrosis (CF) care? Thanks to advancements in medical science, the outlook for people with CF has improved a lot in recent decades. Scientists continue to develop new drugs and strategies to improve the lives of people with CF. Let’s take a look at some of the latest developments. Updated guidelines to improve personalized care In 2017, experts from the Cystic Fibrosis Foundation released updated guidelines for diagnosing and classifying CF. These guidelines might help doctors recommend more personalized approaches to treating CF. Over the past decade, scientists have developed a better understanding of the genetic mutations that can cause CF. Researchers have also developed new drugs to treat people with certain types of genetic mutations. The new guidelines for diagnosing CF might help doctors determine who is most likely to benefit from certain treatments, based on their specific genes. New drugs to treat the underlying cause of symptoms CFTR modulators can benefit some people with CF, depending on their age and the specific types of genetic mutations they have. These drugs are designed to correct certain defects in CFTR proteins that cause symptoms of CF. While other types of medication […]
Taj Pharmaceuticals’ Specialization Unveiled Taj Pharmaceuticals stands out as a beacon of excellence, particularly in the realm of MUPs, Pellets, DC Granules, and Effervescent Sachets. Let’s delve into the intricacies of their specialization and the vast capacities they bring to the table. Pre-Formulation Intermediates: The Foundation of Excellence MUPs, Pellets, DC Granules, and Taste Mask Granules MUPs, Pellets, DC Granules, and Effervescent Sachets Taj Pharmaceuticals boasts a robust production capacity, emphasizing Micro Pellets (MUPs) at 5000kg per month, Bulk Drugs Pellets at 60 MT per month, and Taste Mask Granules at 50 MT per month. These pre-formulation intermediates set the stage for high-quality pharmaceutical formulations. Effervescent Sachets and Tablets: A Fusion of Science and Innovation Effervescent formulations have gained prominence, and Taj Pharmaceuticals is at the forefront with staggering monthly capacities: Effervescent Sachets: 15 Million Effervescent Tablets: 10 Million General Tablets: 15 Million General Sachets: 20 Million This vast production capacity positions Taj Pharmaceuticals as a reliable supplier in the global pharmaceutical market. Global Quality Approvals: A Testament to Excellence With approvals from GMP, WHO-GMP, ISO, QVCERT-UK, and regulatory bodies in Mexico, Guatemala, Uzbekistan, Algeria, among others, Taj Pharmaceuticals ensures adherence to the highest global standards. Their commitment extends to […]
Though bound by law, neither doctors nor pharmacies want to dispense generic medicines to patients as the profit margin is low Laws in India specify that all medical prescriptions should give generic medicines and all pharmacies must make them available to patients. “Most cancer medicines still remain unaffordable to most Indians because there is no curb on profiteering by pharma manufacturers”. But aggressive marketing by private pharma companies, cut-throat competition and ignorance of the customers coupled with weak enforcement of rules allow private manufactures of branded medicines to make a killing through your “friendly pharmacy”. About 85% of total health expenditure in India is financed by household out-of-pocket expenditure (according to government figures) and medicines constitute 20% to 60% of total healthcare expenditure. Understanding the strain medical expenditure has on the common man, the central government has been working on “aggressive” marketing of generic drugs by opening pharmacies that sell these medicines, and asking pharmacies to display availability of these medicines. Missing display Sadly almost no pharmacy in the Capital seems to be in the mood to cooperate with the government in advertising the availability of generic drugs. “We provide what doctor has prescribed” is the common refrain. But just […]
When the sniffles strike and your nose won’t stop running, it’s time to reach for a reliable cold medicine kit. Taj Pharmaceuticals Limited, a renowned pharmaceutical company headquartered in Mumbai, India, offers a comprehensive solution for those battling a runny nose due to cold or allergies. In this article, we will explore the Taj Pharmaceuticals Runny Nose Cold Medicine Kit, consisting of four essential tablets designed to provide you with relief and comfort during the trying times of a cold. Understanding Taj Pharmaceuticals Limited Before delving into the specifics of the cold medicine kit, let’s get to know Taj Pharmaceuticals Limited a little better. Taj Pharmaceuticals is a prominent player in the pharmaceutical industry, manufacturing and distributing a wide range of medicines. Their product portfolio encompasses prescription solutions, life-saving drugs, anti-cancer medications, veterinary products, consumer brands, and CNS drugs. With a strong focus on various medical conditions such as anemia, anxiety disorders, cancer/oncology, ear infections, heart failure, hepatitis, HIV/AIDS, influenza, non-Hodgkin’s lymphoma, obesity, osteoporosis, Parkinson’s disease, pneumonia, transplantation, and common diseases, Taj Pharmaceuticals stands as a reliable name in healthcare. Global Leader in Generics Taj Pharmaceuticals Limited has earned its reputation as a global leader in generics and ranks among […]
The first biosimilar in India was approved in 2000, and, with the help of legislation and regulation from the Indian Government, the market has continued to grow since, reaching a value of $2.2bn in 2017. However, biosimilars remain challenging to manufacture for Indian pharmaceutical companies, at the emerging end of the market. India has firmly established itself in the global pharmaceutical market; it has been predicted that India will be the sixth largest market for pharmaceuticals by 2020, and the country exported pharmaceutical products worth more than $17bn in 2017-8. Indian pharmaceutical companies are especially known for producing generics, identical copies of branded drugs marketed under different names once the patent for the original drug has run out. Many of these companies are starting to move into the global biosimilars market. According to Associated Chambers of Commerce of India’s 2017 report, biosimilars are worth $2.2bn out of the $32bn total Indian pharmaceutical market and are expected to reach $40bn by 2030, which represents a 30% compound annual growth rate. This growth will be aided by a range of biologic patents expiring in the next few years. Biosimiliars are medicines that are highly similar and clinically equivalent to complex, biologic medicines […]
What is melanoma? | Melanoma Stages | Melanoma Types | Melanoma Risk factors | Melanoma Symptoms | Melanoma Treatment | Prevention melanoma | Melanoma Diagnosis | Melanoma Outlook Melanoma is a type of skin cancer. It is not the most common, but it is the most serious, as it often spreads. When this happens, it can be difficult to treat, and the outlook may be poor. Risk factors for melanoma include overexposure to the sun, having fair skin, and a family history of melanoma, among others. melanoma Receiving an early diagnosis and getting prompt treatment can improve the outlook for people with melanoma. For this reason, people should keep track of any changing or growing moles. Using adequate protection against sun exposure can help a person prevent melanoma altogether. This article covers the symptoms of melanoma, how a doctor would diagnose it, and ways to treat it. We also explain how best to prevent melanoma. What is melanoma? A person may be more at risk of melanoma if they have a family history of the condition. Melanoma is a type of skin cancer that occurs when pigment producing cells called melanocytes mutate and begin to divide uncontrollably. Most pigment cells […]
Remdesivir is considered as a key antiviral drug in the fight against COVID-19, especially in adult patients with severe complications The direction comes against reports of global shortages of the critical drug. Remdesivir is considered as a key antiviral drug in the fight against COVID-19, especially in adult patients with severe complications. The new wave came as a surprise after production was not continued as many countries were more focused on vaccination. The countries such as Venezuela has decided to procure remdesivir injections from Indian firms who can export, so that they could be provided treatment of critical COVID-19 patients from the economically weaker sections.
— Drug to be given to comatose Illinois patient after docs refusedby Jennifer Henderson, Enterprise & Investigative Writer, MedPage Today May 4, 2021 Ivermectin Tablets USP 12 mg (Iverotaj 12) An Illinois judge has ordered a hospital to give ivermectin to a comatose patient with few options left. Judge James Orel of DuPage County ordered Edward-Elmhurst Hospital to allow 68-year-old COVID-19 patient Nurije Fype to receive the drug, even though it isn’t endorsed by federal health agencies, the Chicago Tribune reported. Fox 32 Chicago reported that Fype, who has been in the intensive care unit since early last month and is currently on a ventilator, has since received her first dose. Her daughter, Desareta Fype, enlisted the help of a New York law firm that has taken on other ivermectin cases to force the hospital’s hand after none of its doctors would agree to administer the drug, according to the local media outlets. The Tribune reported Tuesday that an outside doctor was granted credentials at the hospital to administer the ivermectin. “‘Why wouldn’t this be tried if she’s not improving?’” the Tribune quoted Judge Orel as saying during a court hearing. “‘Why does the hospital object to providing this medication? […]
While over 50 different biosimilars already exist in the Indian market, the big money lies launching these drugs in Europe and the United States It has been more than a decade since Indian pharmaceutical companies began looking at the biosimilar opportunity. It is not an easy space to be in and quite unlike their traditional stronghold of generics. However, it is a space that is linked to the nature of future drugs – today, as is often quoted by pharma experts, one out of every three new drugs approved in the global matkets is a biotech drug, specially in fields like cancer care. While over 50 (and counting) different biosimilars already exist in the Indian market, the big money lies launching these drugs in Europe and the United States. So far, hardly a couple of Indian companies have been able to do this and much of this happened in the decade that has just concluded. In February 2015, Intas Pharmaceuticals became the first Indian company to get a biosimilar registered – the biotech drug Filgratsim under the brand Accofil – in the European Union. It is now getting ready to foray into US with more products. “We launched pegylated granulocyte-colony […]
{Taj Pharmaceuticals Limited} : Top Mumbai [generic] manufacturing company What Are Authorized Generics? Authorized generics might just be the answer for drug manufacturers whose patents for their branded drugs have expired. Instead of risking the loss of market share when other drug companies enter the generics marketplace, the brand name manufacturers could develop their own generics. An authorized generic is exactly the same product as an approved branded drug, but is marketed without the brand name on the label. Usually sold at a lower price, it can be marketed by a branded drug company or by another company with the brand company’s permission. “By making an authorized generic, a brand manufacturer gets a jump start on the competition as generics start to appear,” says Karen Berger, PharmD, a staff pharmacist at Plymouth Park Pharmacy in Fair Lawn, NJ. “Authorized generics, which are identical to the brand, should not be confused with a branded generic that has gone through the abbreviated new drug application (ANDA) process and is assigned a name other than its chemical name,” she says. Leaving nothing to chance: “While a separate NDA is not required for marketing an authorized generic, FDA requires that the NDA holder notify the […]
Introduction EU-GMP PICs Certification Taj Pharma’s Global Commitment to Quality Cancer, a formidable adversary, claims millions of lives worldwide each year. Unraveling its elusive causes has long confounded medical experts. However, a beacon of hope emerges from Taj Pharmaceuticals, a trusted Anticancer Medicines Manufacturer from India. Their relentless pursuit of a solution has yielded a diverse range of medications, marking a paradigm shift in cancer treatment. Our Approach to Cancer Treatment Taj Pharmaceuticals asserts that cancer necessitates a multifaceted approach. Recognizing the complexity of the disease, they have developed a spectrum of medications to cater to diverse patient needs. This inclusive strategy ensures that individuals, regardless of geographical location, can benefit from their groundbreaking cancer treatments. The Global Impact of Taj Pharma The positive reverberations of Taj Pharma’s efforts extend far beyond India’s borders. Numerous cancer patients worldwide have experienced significant improvements through the use of Taj Pharmaceuticals‘ products. The company’s commitment to global well-being is evident in the widespread success and endorsement of their cancer treatments. Comprehensive Product Range Anti-Cancer Tablets Taj Pharmaceuticals specializes in the manufacturing and export of a wide array of anti-cancer tablets. Notable offerings include Erlotinib, Capecitabine, Gefitinib, and Imatinib. These medications have undergone rigorous […]
Proton Pump Inhibitors (PPI) Formulations: A Comprehensive Guide In the realm of medical advancements, proton pump inhibitors (PPIs) have emerged as a critical class of medications, playing a pivotal role in treating a diverse range of acid-related disorders. This comprehensive guide aims to delve deep into the world of PPIs, shedding light on their indications, mechanism of action, contraindications, and various other essential aspects that contribute to their effectiveness in managing acid-related pathologies. Unveiling the Power of Proton Pump Inhibitors (PPIs) Understanding PPIs: An Overview Proton pump inhibitors, often referred to as PPIs, form a class of medications that hold the key to managing disorders originating from excessive stomach acid production. These compounds act by inhibiting the proton pump in the gastric lining, thereby significantly reducing the secretion of hydrochloric acid into the stomach. This, in turn, plays a crucial role in alleviating the symptoms associated with various acid-related conditions. The Role of PPIs: Indications and Action PPIs have garnered widespread recognition for their efficacy in addressing a spectrum of acid-related disorders. They are commonly prescribed for conditions such as gastroesophageal reflux disease (GERD), peptic ulcers, Zollinger-Ellison syndrome, and more. The mechanism of action revolves around the inhibition of the […]
It might be difficult to implement compulsory prescription of generics The enforcement by the drug regulator will not be easy given the shortage of drug inspectors – {Taj Pharmaceuticals Generic Drug Division} Prime Minister Narendra Modi wants to defeat the doctor-pharmaceutical company nexus and make medicines affordable by making it compulsory to prescribe drugs in the generic name. But, the good intentions may not give the desired results. The enforcement will not be easy given the shortage of drug inspectors. At an industry event at Surat last month, Modi announced plans for a new law to make generic prescriptions mandatory. Parallelly the government is already initiating steps to push for generic prescriptions. In a recent communication to all the states, the Centre has asked states to make sure all physicians write generic names of drugs in a legible manner. Business Standard has reviewed the letter. The government has issued a draft amendment which will make it mandatory for companies to print generic names of the drug in a bolder font than the brand name on the packaging. But, the government will face a difficult task in enforcing its decisions. Food and Drug Administration offices across the country are short staffed. […]
The higher price of new cancer drugs is rarely justified Most cancer drugs introduced since 2004 provide low added value compared to previously approved medications, but have much higher prices, according to a French study presented at the congress of the European Society for Medical Oncology (ESMO 2019) currently underway in Barcelona. Taj Oncology «Most of the new cancer drugs had low added value, so doctors and patients shouldn’t assume that just because a drug is new, it’s going to be better» said Marc Rodwin, Suffolk University, Boston (USA), co-author of the study. Researchers calculated the correlation between prices and value of medications for solid tumors registered by the European Medicines Agency (EMA) from 2004 to 2017. They found that 48% of drugs had low added value on the ESMO Magnitude of Clinical Benefit Scale (ESMO-MCBS) and 70% scored equally low on the and Added Therapeutic Benefit Ranking (ASMR). Overall, new drugs were in average 2,500 euro more expensive than their older counterpart, but this price increase price did not correlate with added value. A second study analysed 63 new drugs for adult solid (46) and hematologic (17) cancers approved by the US Food and Drug Administration from 2009-2017 and approved […]
Pharmaceutical firm Taj Pharma has announced that it has introduced Covid-19 treatment drug Molnupiravir under brand name “Molnutaj” in India. Molnupiravir is for treatment of adult patients hospitalised with COVID-19, under certain conditions, drug maker said.
The test can run on small machines the size of a toaster; A daily Covid-19 update from Taj Pharmaceuticals Limited Coronavirus Latest Breaking News, Coronavirus Treatments, Coronavirus Clinical Trials, and Special Reports on COVID-19.